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ABSTRACT 
Christie N. Jones: Structural and mechanistic studies of mammalian mitochondrial RNAs 
(Under the direction of Linda L. Spremulli) 
The mammalian mitochondrial genome encodes 13 proteins, which are synthesized at 
the direction of 9 monocistronic and two dicistronic mRNAs. These mRNAs lack both 5' and 
3' untranslated regions. The mechanism by which the specialized mitochondrial translational 
apparatus locates start codons and initiates translation of these leaderless mRNAs is currently 
unknown. To better understand this mechanism, the secondary structures near the start 
codons of all 13 open reading frames have been analyzed using RNA SHAPE chemistry. The 
extent of structure in these mRNAs as assessed experimentally is distinctly lower than would 
be predicted by current algorithms based on free energy minimization alone. We find that the 
5' ends of all mitochondrial mRNAs are highly unstructured. The first 35 nucleotides for all 
mitochondrial mRNAs form structures with free energies less favorable than -3 kcal/mol, 
equal to or less than a single typical base pair. The start codons, which lie at the very 5' ends 
of these mRNAs, are accessible within single stranded motifs in all cases, making them 
potentially poised for ribosome binding.  These data are consistent with a model in which the 
specialized mitochondrial ribosome preferentially allows passage of unstructured 5' 
sequences into the mRNA entrance site to participate in translation initiation. 
The mitochondrial tRNA genes are hot spots for mutations that lead to human 
disease. A single point mutation (T4409C) in the gene for human mitochondrial tRNA
Met
 
(hmtRNA
Met
) has been found to cause mitochondrial myopathy. This mutation results in the 
ii
replacement of U8 in hmtRNA
Met
 with a C8. Here we show that the single U8C mutation 
leads to a failure of the tRNA to respond conformationally to Mg
2+
.  This mutation results in 
a drastic disruption in the structure of the hmtRNA
Met
, which significantly reduces its 
aminoacylation. We have used structural probing and molecular reconstitution experiments 
to examine the structures formed by the normal and mutated tRNAs.  In the presence of Mg
2+
 
the normal tRNA displays the structural features expected of a tRNA. However, even in the 
presence of Mg
2+
, the mutated tRNA does not form the cloverleaf structure typical of tRNAs.  
Thus, we believe that this mutation has disrupted a critical Mg
2+
 binding site on the tRNA 
required for formation of the biologically active structure. This work establishes a foundation 
for understanding the physiological consequences of the numerous mitochondrial tRNA 
mutations that result in disease in humans.  
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CHAPTER 1 
MECHANISM OF PROTEIN SYNTHESIS 
   
 
 
INTRODUCTION 
 
 Mitochondria are membrane bound, subcellular organelles found in eukaryotic cells. 
They are believed to have derived from bacteria that were engulfed by early eukaryotic cell 
precursors. Mitochondria are known as the powerhouses of the cell and through oxidative 
phosphorylation (OXPHOS) generate 90% of the cell’s energy in the form of ATP. Present in 
the inner membrane of the mitochondrion are a series of multi-protein complexes through 
which electrons are transported and ultimately delivered to molecular oxygen (Fig. 1-1). 
Electron transport generates an electrochemical proton gradient across the membrane; the 
flow of protons back across the membrane drives the formation of ATP by the ATP synthase 
complex (1).  
 There are over 80 proteins that constitute the OXPHOS machinery. The majority of 
these proteins are encoded within the nuclear genome, translated in the cytoplasm and 
imported into the mitochondrion. However, a few of the protein subunits are encoded within 
the unique mitochondrial genome. The size and content of the mitochondrial genome varies 
greatly across species. For example, the mitochondrial genome of plants is commonly greater 
than 100 kilo base pairs (kbp) compared to the human mitochondrial genome of only about 
13 kbp. The human mitochondrial genome is small and compact encoding only 13 proteins 
that all function in OXPHOS and also encodes 2 rRNAs and 22 tRNAs (Fig. 1-2). The 
double-stranded, circular genome is organized so that 12 of 13 protein encoding genes are 
encoded on a single strand of the genome. The protein encoding genes are delineated by the 
tRNA genes that are dispersed on both strands of the genome (2).  
2
FIGURE 1-1. The inner mitochondrial membrane showing the oxidative phosphorylation 
pathway.  Electrons are transferred from NADH through the 4 complexes of the electron 
transfer chain: complex I (NADH dehydrogenase), complex II (succinate dehydrogenase, not 
shown), complex III (cytochrome reductase) and complex IV (cytochrome oxidase). From 
complex IV, the electrons reduce molecular oxygen to water. The flow of electrons through 
the complexes provides the energy used to pump protons across the inner membrane, from 
the matrix to the intermembrane space, forming a proton gradient. The flow of protons down 
the concentration gradient, through complex V (ATP synthase), results in the formation of 
ATP from ADP and inorganic phosphate (Pi). 
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FIGURE 1-2. Organization of the human mitochondrial genome. The mitochondrial genome 
encodes 13 protein subunits of the oxidative phosphorylation pathway (pink, purple, orange 
and yellow). In addition, the genome encodes all 22 tRNAs (white) and the 2 rRNAs (green) 
required for protein synthesis in mammalian mitochondria. The tRNA genes are designated 
by their 1 letter amino acid abbreviation. The origins of replication (OH and OL) and 
transcription promoters (PH and PL) are shown. This figure was taken and modified from 
www.mitomap.org. 
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 An unavoidable by-product of OXPHOS is the generation of reactive oxygen species 
(ROS), such as superoxide. Most of the ROS generated in mitochondria are scavenged by 
enzymes or non-enzymatic antioxidants (3). However, damage to the mitochondrial DNA 
(mtDNA) by ROS does occur. The close proximity of the mtDNA, in the matrix of the 
mitochondrion, to the ROS generating OXPHOS pathway leads to a much higher mutation 
rate compared to nuclear DNA. Mitochondrial polymerases lack base-excision repair so are 
ill equipped to deal with ROS-induced DNA damage. Therefore, mutations are prevalent in 
mitochondrial DNA (3,4).  
 There are multiple mitochondria in each cell and 100-10,000 copies of mtDNA in 
each mitochondrion. Mutations that are caused by ROS induced damage may only affect a 
subset of the mtDNA. When a mutation is only present in some copies of the mtDNA the 
mutation is considered heteroplasmic. A mutation present in all copies is homoplasmic. For 
heteroplasmic mutations, a critical number of mutated mtDNA copies must be present in a 
mitochondrion for disease to result. Therefore, the onset of disease and loss of energy 
production may be gradual and may depend on the cell type affected (5,6). 
 Diseases caused by mutation of mtDNA can result from damage to one of the 
mitochondrial encoded OXPHOS proteins or may result from damage to one of the tRNAs. 
While the rate of mtDNA mutation is generally high, the mutation rate of the tRNAs is 
disproportionately high. The tRNA genes only constitute ~10% of the genome, but account 
for over half of the disease causing mutations (4,7). The mitochondrial tRNAs are, therefore, 
considered hotspots for mutations that cause disease in humans.  
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PROTEIN SYNTHESIS IN PROKARYOTES 
 
 The mechanism of protein synthesis in prokaryotes occurs on the 70S ribosome (Fig. 
1-3). The 70S ribosome is composed of two subunits; both the large subunit (50S) and the 
small subunit (30S) are required for protein synthesis along with additional protein factors, 
tRNAs and mRNA. The ribosome is composed of multiple protein and RNA components that 
are assembled to form the protein synthesizing ribozyme. The ribosome contains 3 sites: the 
aminoacyl-tRNA site (A-site) where aminoacyl-tRNAs are delivered, the peptidyl site (P-
site) where the peptide carrying tRNA is positioned and the exit site (E-site) where 
deacylated tRNAs are positioned for release. The 30S subunit contains the mRNA binding 
cleft and the catalytic peptidyl transferase center is on the 50S subunit (Fig. 1-3) (8).   
 The mechanism of protein synthesis is divided into 3 phases: initiation, elongation 
and termination (Fig. 1-4). During initiation the ribosome loads onto the mRNA, the start 
codon of the mRNA is located and positioned at the P-site of the ribosome and finally the 
initiator tRNA (fMet-tRNA
Met
f
) binds to the P-site of the ribosome forming the correct 
codon/anticodon interaction. Subsequently, during the elongation phase, amino acids are 
added to a growing peptide chain in response to the mRNA codon sequence. Finally, during 
termination a stop codon is positioned at the A-site of the ribosome signaling the end of 
protein synthesis, release of the newly formed peptide and dissociation of the ribosome (9). 
 
Initiation phase of protein synthesis 
 The current model for initiation of protein synthesis in prokaryotes (Fig. 1-5) begins 
by dissociation of the 70S ribosome into its 30S and 50S subunits. Initiation factor 3 (IF3) 
8
FIGURE 1-3. X-ray crystal structure of the T. thermophilus 70S ribosome and subunits at 
5.5Å resolution. (A) The crystal structure of the 30S ribosomal subunit viewed from the 
subunit interface side. The subunit is shown with mRNA (pink) and tRNAs positioned at the 
A-site (red), P-site (green) and E-site (yellow). The decoding center near the A-site is 
indicated by an arrow. (B) The crystal structure of the 50S subunit viewed from the subunit 
interface side. The subunit is shown with tRNAs at the 3 sites (colored as in A). The peptidyl 
transferease center where peptide bonds are formed is circled. (C) The crystal structure of the 
70S ribosome with the 30S (blue) and 50S (yellow) subunits shown. The 3 tRNA binding 
sites are visible at the subunit interface. Based on (31). 
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FIGURE 1-4. Cartoon representation of the three phases of protein synthesis: initiation, 
elongation and termination. During initiation the ribosome (green) must locate the start 
codon of the mRNA (blue) and form the proper codon:anticodon interaction with the initiator 
tRNA at the P-site of the ribosome. After initiation the cyclic elongation phase begins. 
During elongation the ribosome and mRNA move exactly 3 nucleotides relative to one 
another signaling delivery of a new amino acid, the newly delivered amino acids are 
incorporated into the nascent peptide chain (pink). When a stop codon is positioned at the A-
site then termination occurs and the ribosomal subunits, peptide and mRNA are released. 
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FIGURE 1-5. A model for the initiation phase of protein synthesis in prokaryotes. Initiation 
begins with the 70S ribosome in equilibrium with its 50S and 30S subunits. Binding of IF3 to 
the 30S subunit shifts the equilibrium toward dissociation of the ribosome. IF1 and IF2 then 
bind to the 30S subunit, followed by the initiator fMet-tRNA and the mRNA to form the pre-
initiation complex. The 30S initiation complex is formed when the mRNA is properly 
positioned with its start codon at the P-site of the ribosome. The binding of the 50S subunit to 
the 30S initiation complex results in release of the initiation factors and formation of the 70S 
initiation complex. The  70S initiation complex is prepared for the elongation phase of 
protein synthesis.  
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binds to the 30S subunit preventing its re-association with the 50S subunit and initiation 
factor 1 (IF1) binds to the 30S:IF3 complex to prevent premature binding of aminoacyl-
tRNAs (aa-tRNAs) (10). Subsequently, initiation factor 2 (IF2) binds to the complex to 
stimulate binding of the initiator fMet-tRNA
Met
f
 to the P-site of the ribosome. To facilitate 
proper positioning of the complex on the mRNA the initiation factor:30S complex recognizes 
and binds to the Shine-Dalgarno sequence to form a pre-initiation complex. A stable 
initiation complex is formed when the correct codon:anticodon interaction occurs at the P-
site of the 30S subunit. Once the 30S initiation complex is formed the 50S subunit binds to 
the complex triggering release of the initiation factors. The 70S initiation complex is then 
poised to enter the elongation phase of protein synthesis.  
 
Elongation phase of protein synthesis 
 The elongation phase begins with the 70S initiation complex containing the fMet-
tRNA
Met
f
 at the P-site of the ribosome and empty A- and E-sites. The mRNA is positioned 
with the AUG start codon forming a codon:anticodon interaction at the P-site of the ribosome 
with the second codon positioned at the A-site. An aa-tRNA is delivered to the A-site as a 
ternary complex with EF-Tu and GTP. The tRNA delivered depends on the identity of the 
codon at the A-site. A cognate codon:anticodon interaction achieved at the A-site of the 
ribosome triggers hydrolysis of GTP from the ternary complex and release of EF-Tu:GDP 
from the ribosome. The EF-Tu:GDP complex interacts with its guanine nucleotide exchange 
factor EF-Ts off the ribosome to re-generate the active EF-Tu:GTP complex that can then 
bind an additional aa-tRNA. On the ribosome, the P-site amino acid (formylmethionine) is 
transferred to the amino acid of the newly delivered A-site aa-tRNA and a peptide bond is 
15
   
 
 
formed through the action of the peptidyl transferase center on the 50S subunit. This reaction 
leaves a deacylated tRNA at the P-site and a peptidyl-tRNA at the A-site. The G-protein, 
elongation factor G (EF-G), then catalyzes the translocation event that places the deacylated 
tRNA at the E-site, the peptidyl-tRNA at the P-site and moves the ribosome exactly 3 
nucleotides relative to the mRNA placing a new codon at the A-site. The cyclic process then 
proceeds as a new ternary complex is delivered to the A-site (Fig. 1-6) (9). 
 
Termination phase of protein synthesis 
 Termination occurs when the codon present at the A-site of the ribosome is a stop 
codon. This triggers binding of either release factor 1 (RF-1) or release factor 2 (RF-2), both 
tRNA mimics, to the A-site.  RF-1 recognizes the stop codons UAG or UAA and RF-2 
recognizes UAA or UGA. Release factor 3 (RF-3) then binds to either RF-1 or RF-2 causing 
the release of either RF-1 or -2 from the A-site and release of the nascent peptide from the P-
site. Subsequently, the GTP of RF-3 is hydrolyzed releasing the factor from the ribosome. 
The binding of the ribosome recycling factor (RRF) and EF-G to the ribosome signals release 
of the deacylated P-site tRNA and the mRNA from the ribosome (9).  
 
PROTEIN SYNTHESIS IN MITOCHONDRIA 
 
 The mechanism of protein synthesis in prokaryotes is used as a foundation for 
understanding this mechanism in mammalian mitochondria. The similarity between the two 
mechanisms is largely attributed to the homology between the translation factors involved in 
protein synthesis and similarities in antibiotic sensitivity (1). Though the basic mechanisms 
16
FIGURE 1-6. A model for the elongation phase of protein synthesis in prokaryotes. 
Elongation is a cycle which begins with a deacylated tRNA at the E-site of the ribosome 
ready for release and a peptidyl-tRNA at the P-site. The next aa-tRNA is delivered to the A-
site of the ribosome in complex with EF-Tu and GTP and the deacylated-tRNA is released. 
Once the new aa-tRNA is delivered to the A-site, GTP is hydrolyzed and the EF-Tu:GDP 
complex is released. A peptide bond is formed between the A-site amino acid and the P-site 
peptide to form a peptide that is one amino acid longer and is positioned at the A-site. EF-G 
catalyzes the movement of the ribosome along the mRNA in a GTP dependent manner, once 
again placing a deacylated-tRNA at the E-site for release and the peptidyl-tRNA at the P-site. 
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are similar, important differences exist (Table 1-1). In the following paragraphs the two 
systems will be compared. 
 
Mitochondrial ribosomes 
 The mitochondrial ribosome is quite different from the ribosomes found in 
prokaryotes though they share a similar function. The mitochondrial ribosome is composed 
of 2/3 protein and only 1/3 RNA, while the prokaryotic ribosome is 2/3 RNA and 1/3 protein. 
The mitochondrial ribosome (2.7 MDa, 55S) has a larger molecular weight than the 
prokaryotic ribosome (2.3 MDa, 70S), but its smaller sedimentation coefficient suggests the 
particle is less dense. The mitochondrial ribosome, like the bacterial ribosome, is composed 
of two subunits. However, the mitochondrial subunits are 28S and 39S, compared to the 30S 
and 50S subunits of prokaryotes (11). 
 
Mitochondrial mRNAs 
 In mammalian mitochondria the mRNAs differ in both structure and genetic code 
from prokaryotic mRNAs. In prokaryotes, the canonical mRNA contains the Shine-Dalgarno 
(SD) sequence upstream of the start codon, this sequence base pairs with the anti-SD 
sequence at the 3′ end of the 16S rRNA of the small subunit and is important for placement 
of the start codon at the P-site of the ribosome for initiation. Mitochondrial mRNAs lack the 
SD sequence and the anti-SD sequence is missing from the small subunits RNA.  
Mitochondrial mRNAs are also not capped on the 5′ end like cytoplasmic eukaryotic 
mRNAs. They are, however, polyadenylated on their 3′ ends like the mRNAs in the 
cytoplasm of eukaryotes. Interestingly, the genetic code used in mitochondria also differs 
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from that found in both prokaryotes and the cytoplasm of eukaryotes. Mammalian 
mitochondria use both AUG and AUA as methionine codons, but canonically AUA codes for 
isoleucine. Also, UGA has been reassigned as a tryptophan codon instead of a stop codon. In 
addition to the canonical UAA and UAG stop codons, mammalian mitochondria also use 
AGA and AGG as stop codons instead of as arginine codons. 
 
Mitochondrial initiation factors 
 Mitochondrial translation factors are homologous to prokaryotic factors and generally 
share their function, but significant differences also exist. Mitochondria contain IF2 and IF3 
homologs (IF2mt and IF3mt), but a homolog of IF1 has not been identified. IF2mt is an ~85 
kDa G-protein. Like its prokaryotic homolog the primary function of IF2mt is to promote the 
binding of fMet-tRNA
Met
f
 to the small ribosomal subunit during initiation. E. coli IF2 is a 6 
domain protein (12). IF2mt has domains corresponding to III-VI of the E. coli factor (13) and 
contains a 37 amino acid insertion between domains V and VI (Fig. 1-7). Recent work has 
shown that in the presence of IF2mt, an E. coli IF2 knockout no longer requires IF1, 
suggesting that the IF2mt insertion may play the role of IF1 in mitochondria (14).   
 IF3mt shares only 20-26% identity with prokaryotic IF3. Though only partially 
homologous, IF3mt performs many of the same functions as its prokaryotic homologs 
including an ability to dissociate ribosomes and to stimulate initiation complex formation 
(15). The mitochondrial factor contains extension on both its N- and C-terminal ends (Fig. 1-
8) and the role of these extensions has recently been reported. Derivatives of the protein 
lacking the extensions have been shown to have an increased affinity for binding to the 39S 
21
FIGURE 1-7. Domain organization of E. coli and mitochondrial IF2. E. coli IF2 is a 6 
domain G-protein that stabilizes the initiator tRNA at the P-site of the ribosome during 
initiation. The homologous mitochondrial IF2 (IF2mt) lacks domains I and II and contains an 
insertion between domains V and VI that is postulated to functional replace IF1 in 
mitochondrial protein synthesis. 
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FIGURE 1-8. Domain organization of E. coli and mitochondrial IF3. E. coli IF3 contains 2 
domains separated by a flexible linker and during initiation dissociates the ribosome into 
subunits and promotes initiation complex formation. The homologous mitochondrial IF3 
(IF3mt) contains N- and C-terminal extensions. These extensions prevent IF3mt from 
detrimental binding to the 39S subunit and allow for IF3mt dissociation upon 39S joining. 
IF3mt also contains an N-terminal mitochondrial important leader sequence. 
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subunit, suggesting that the role of the extensions is to allow proper dissociation of the factor 
from the ribosome upon 39S joining (16).  
 
Mitochondrial tRNA
Met
 
 The initiator tRNA in mammalian mitochondria differs substantially from that found 
in prokaryotes (Fig. 1-9). In prokaryotes and the cytoplasm of eukaryotes there are separate 
tRNA
Met
 species that function as either the initiator tRNA or as an elongator tRNA. 
However, in mammalian mitochondria there is a single tRNA
Met
. This single tRNA functions 
in both elongation and is formylated for use in initiation. This single tRNA also decodes both 
the AUG and AUA codons (17,18). The multiple roles of this tRNA, necessitates that the 
tRNA be structurally unique from canonical initiator tRNAs. Canonical initiator tRNAs are 
characterized by a set of structural features which are important for their function. The 
mammalian mitochondrial tRNA
Met
 contains some of the features characteristic of an initiator 
tRNA, but some of these features are conspicuously absent, while other interesting features 
are present.  
 Most initiator tRNAs, including the mammalian mitochondrial tRNA
Met
, contain an 
anticodon stem with a GGG●CCC sequence forming 3 consecutive G:C base pairs. The GC 
pairs are important for targeting the tRNA to the P-site of the ribosome for use in initiation. 
This structural element likely affects the structure of the adjacent anticodon loop and may 
affect the ability of the loop to be accommodated at the P-site of the ribosome. The G:C 
structural element may also form important interactions with the ribosome itself. 
 Following the anticodon stem is a 7 nucleotide loop that is conserved from 
prokaryotes to mitochondria. Interestingly, animal mitochondrial tRNA
Met
 contains an 
26
FIGURE 1-9.  Comparison of E. coli initiator tRNA and human mitochondrial tRNA
Met
. (A) 
The E. coli initiator tRNA contains the structural elements that characterize prokaryotic 
initiator tRNAs. These features include the 3 consecutive G●C base pairs (pink) at the base 
of the anticodon stem, the conserved Pu11●Py24 base pair (orange) in the D-stem and the 
non-Watson-Crick base pair at the top of the acceptor stem (green). (B) The human 
mitochondrial tRNA
Met
 (hmtRNA
Met
) contains some of the elements that characterize 
prokaryotic initiator tRNAs, but lacks others. HmtRNA
Met
 contains the 3 consecutive G●C 
base pairs and the Pu11●Py24 base pair. However, hmtRNAMet contains a weak A●U base 
pair at the top of the acceptor stem, more similar to an elongator tRNA. HmtRNA
Met
 contains 
features of both an initiator and an elongator tRNA, which is necessary because the tRNA 
must function in both initiation and elongation.  
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unusual 5-formylcytosine modification at position 34 of the anticodon loop (17-19). We are 
currently investigating whether this unique modification may be important for allowing the 
hmtRNA to decode both the AUG and AUA codons.  
 One of the most important elements distinguishing initiator and elongator tRNAs is 
the base pair at the top of the acceptor stem. Prokaryotic initiator tRNAs never contain a 
Watson-Crick base pair at the top of the acceptor stem. This mismatch serves as an anti-
determinant, preventing the initiator tRNA from binding to EF-Tu and being used in 
elongation. The prokaryotic elongator tRNA, however, has a strong G:C base pair at this 
position. Mutagenesis has shown that a tRNA with a weaker A:U base pair at this position 
interacts with EF-Tu more weakly than a tRNA with a strong G:C (20). The hmtRNA
Met
, 
interestingly, contains the weaker A:U base pair at this position. In this way, the hmtRNA
Met
 
resembles a weak elongator tRNA.  
 In the D-stem of prokaryotic initiator tRNAs a conserved base pair exists between a 
purine at 11 and a pyrimidine at 24 (Pu11●Py24) and in elongator tRNAs the opposite base 
pair (Py11●Pu24) exists (20). The importance of this conserved Pu11●Py24 interaction is 
unknown. It is, however, conserved in the hmtRNA
Met
. It is possible that this interaction is 
important for formylation of the tRNA for use in initiation (20).  
 The dual role of hmtRNA
Met
 in both initiation and elongation requires that the tRNA 
interact with protein factors involved in both phases of translation (Fig. 1-10). To be used 
during protein synthesis the tRNA must be aminoacylated by the human mitochondrial 
methionyl-tRNA synthetase (hmMetRS) to form Met-tRNA
Met
. The Met-tRNA must then 
bind to EF-Tumt:GTP to form the ternary complex for delivery to the A-site of the ribosome 
during elongation. Conversely, Met-tRNA must also be formylated by the human 
29
FIGURE 1-10.  The life cycle of human mitochondrial tRNA
Met
 (hmtRNA
Met
). HmtRNA
Met
 
is used in both the initiation and elongation phases of protein synthesis in mitochondria. The 
tRNA must first be aminoacylated by hmMetRS to form Met-tRNA. Once aminoacylated, 
the Met-tRNA can be formylated by MTFmt to form fMet-tRNA, which is then delivered to 
the P-site of the ribosome for use in initiation. Conversely, the Met-tRNA can bind to EF-Tu 
for delivery to the A-site of the ribosome during elongation. 
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mitochondrial methionyl-tRNA transformylase (hmMTF) to form fMet-tRNA
Met
 for delivery 
to the P-site of the ribosome during initiation. This complex life cycle of hmtRNA
Met
 is 
unique to mammalian mitochondria. A more thorough understanding of how the tRNA is 
partitioned between the initiation and elongation phases of protein synthesis is being pursued.  
 For hmtRNA
Met
 to be used in either phase of translation it must first be aminoacylated 
by hmMetRS to form Met-tRNA. HmMetRS is homologous to its prokaryotic counterpart, E. 
coli MetRS, and both enzymes are categorized as Class I synthetases (21). The enzyme 
functions in a multi step process, in the first step the carboxyl group of methionine is 
activated by attachment of the amino acid to the α-phosphate of ATP to form the 5′-
aminoacyl adenylate. In the second step, the amino acid is transferred to the 2′-OH of the 
terminal A residue in tRNA
Met
 and AMP is released. During the spontaneous 
transesterification step the amino acid is transferred from the 2′-OH to the 3′-OH of the 
terminal residue to form Met-tRNA. Class II synthetases add the amino acid directly to the 
3′-OH of the terminal residue, thereby avoiding the transesterification step (22). 
 MetRS, like other class I synthetases, is characterized by conserved structural 
elements (22). The catalytic center contains a Rossman fold (pink in Fig. 1-11) with the 
HIGH signature sequence. The two halves of the Rossman fold are separated by a 
connectivity peptide (CP, green in Fig. 1-11). In E. coli the CP domain contains a Zn
2+
 
binding knuckle structure. The Zn
2+
 binding region is absent in hmMetRS (23). Following 
the Rossman fold is a small domain containing the signature sequence KMSKS (orange in 
Fig. 1-11). The C-terminal domain (blue in Fig. 1-11) follows and packs against the KMSKS 
domain (24). An insertion helix in the Rossman domain, along with the CP domain, is 
thought to be important for positioning the acceptor helix of the tRNA at the catalytic site of 
32
FIGURE 1-11.  Crystal structure of E. coli MetRS and domain alignment of E. coli and 
hmMetRS. (A) Domain alignment of hmMetRS with E. coli MetRS. The enzyme is 
composed of 4 domains. The Rossman fold domain (pink) is separated by a connectivity 
peptide (green), which in E. coli MetRS binds Zn
2+
. The Rossman domain is followed by the 
KMSKS domain (orange) and the C-terminal domain (blue). E. coli MetRS contains an 
extension on its C-terminus and hmMetRS has an N-terminal signal sequence for import into 
mitochondria. (B) X-ray crystal structure of E. coli MetRS at 2Å resolution (1qqt). The 
domains are colored as in (A). The location of the single Zn
2+
 that binds to E. coli MetRS is 
shown as a black sphere in the connective peptide. 
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the Rossman domain (24).  Methionine binds in a cleft formed between two helices of the 
Rossman fold (24). Residues in the C-terminal domain serve as either positive or negative 
determinants for tRNA binding, allowing only tRNAs with the CAU anticodon to bind (24). 
In this way, MetRS specifically aminoacylates only tRNA
Met
. 
 Once aminoacylated, human mitochondrial Met-tRNA
Met
 can either be formylated by 
MTFmt for use in initiation or bind to EF-Tu for use in elongation. MTFmt catalyzes the 
transfer of a formyl group from N
10
-formyltetrahydrofolate to the amino group of methionine 
to form N-formylmethionine (25,26). MTFmt is homologous to E. coli MTF which is a two 
domain protein separated by a linker (Fig. 1-12) (27). The E. coli enzyme requires several 
structural elements in its substrate tRNA: a mismatch at the top of the acceptor stem, a 
Pu11●Py24 base pair in the D-stem, a G2●C71 base pair in the acceptor stem, A at position 
73 and aminoacylation of the tRNA with methionine (28). The E. coli initiator tRNA is 
positioned with its D-stem contacting the C-terminal domain of E. coli MetRS and a loop of 
the enzyme near the active site contacting the acceptor stem. In contrast, MTFmt, lacks the 
active site loop so is not expected to make extensive contact with the acceptor stem of Met-
tRNA (26). This is supported by evidence that MTFmt does not require a G2●C71 base pair 
or a mismatch at the top of the acceptor stem. Interestingly, MTFmt is sensitive to the 
presence of a Pu11●Py24 base pair in the D-stem, so the interactions of this stem with the 
enzyme may be similar to those occurring with the E. coli enzyme. The major determinate 
for formylation by MTFmt appears to be the identity of the amino acid (methionine) and 
secondarily the presence of the Pu11●Py24 base pair (26). 
 For human mitochondrial Met-tRNA
Met
 to be used during elongation it must be 
sequestered by EF-Tumt to prevent formylation. EF-Tu binds GTP and aa-tRNA to form a 
35
FIGURE 1-12.  Crystal structure and domain organization of E. coli MTF. (A) E. coli MTF 
is composed of an N-terminal domain (blue) and a C-terminal domain (pink) separated by an 
elongated linker (green). (B) X-ray crystal structure of E. coli MTF at 2Å resolution (1fmt). 
The domains are colored as in (A).  
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ternary complex (EF-Tumt:GTP:aa-tRNA). The ternary complex delivers the aa-tRNA to the 
A-site of the ribosome. GTP hydrolysis triggers release of EF-Tu:GDP from the ribosome. 
Subsequently, EF-Tsmt exchanges GDP for GTP on EF-Tu to form the aa-tRNA binding 
competent EF-Tu:GTP complex. 
 EF-Tumt is a ~46 kDa G-protein composed of 3 domains (29) (EF-Tumt:GDP, Fig. 1-
13) and is highly homologous to prokaryotic EF-Tu. The N-terminal domain, domain 1, of 
EF-Tumt binds GTP/GDP and an associated Mg
2+
.  A crystal structure of the ternary complex 
formed between T. aquaticus EF-Tu, GDPNP and yeast Phe-tRNA shows that the 3′ end of 
the aa-tRNA binds between domains 2 and 3 of EF-Tu and that the 5′ end of the aa-tRNA 
contacts all three domains (30). When compared to T. aquaticus and E. coli EF-Tu, EF-Tumt 
contains an extra helical region at its C-terminus. This extra helix is modeled to contact the 
tRNA. This additional contact may be important for stabilizing the weakly structured 
mitochondrial tRNAs in the ternary complex (29). 
 
 
 
 
 
 
 
 
 
 
38
FIGURE 1-13.  Crystal structure of bovine EF-Tumt bound to GDP at 1.94Å resolution (PDB 
1d2e). EF-Tumt is composed of 3 structural domains. The N-terminal domain (domain 1, 
blue) binds GTP/GDP (orange) with an associated magnesium ion (Mg
2+
, black). Domain 1 
is connected to domain 2 (pink) by a linker (grey). The 3′ end of aa-tRNAs is predicted to 
bind between domains 2 and 3 (green) and the 5′ end is believed to interact with all 3 
domains (aa-tRNA not shown). 
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CHAPTER II 
 
LACK OF SECONDARY STRUCTURE CHARACTERIZES THE 5′ ENDS OF 
MAMMALIAN MITOCHONDRIAL mRNAs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RNA (2008), 14:862-871 
(This work was in collaboration with Kim Hung, Kevin Wilkinson and Kevin Weeks) 
INTRODUCTION 
 
Mammalian mitochondria contain a double stranded genome of approximately 16 
kilobase pairs (1,2). Encoded within the genome are 13 membrane proteins that function in 
the electron transfer chain or are components of the ATP synthase complex. The 13 
mitochondrially encoded proteins are translated from 9 monocistronic and 2 dicistronic 
mRNAs. Both dicistronic mRNAs contain overlapping reading frames (1,2) (Fig. 2-1A). 
With the exception of the two internal start sites found in the dicistronic mRNAs, the 
remaining 11 start sites are located at or near the 5′ end of each mRNA (3). These mRNAs 
therefore have no 5′ untranslated region and are leaderless. These leaderless mRNAs are 
translated by the specialized protein biosynthetic system found in mitochondria. The start 
codon at the 5′ end can be either AUG or AUA, both of which encode methionine in 
mammalian mitochondria. These codons direct the insertion of formylmethionine during 
initiation and methionine during chain elongation. In bovine mitochondria, AUG serves as 
the start codon for 10 genes while AUA is used for the remaining three genes.  
An early and fundamental step in protein synthesis is recognition of the start codon in 
the mRNA by the ribosomal small subunit. This process is achieved by different, well 
established, mechanisms in prokaryotes and for nuclear encoded genes in eukaryotes. In 
prokaryotes, most mRNAs have an untranslated region upstream of the start codon that 
contains the Shine/Dalgarno (SD) sequence. This sequence base pairs with the anti-
Shine/Dalgarno sequence in the 16S rRNA of the 30S subunit and positions the mRNA start 
codon at the P-site of the ribosome (4,5). In addition to the simple presence of the SD 
sequence, the physical accessibility of the SD sequence and its associated start codon is a 
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major determinant for translational initiation in prokaryotes (6,7). The underlying secondary 
structure of the mRNA can function to prevent initiation at incorrect methionine codons and 
to facilitate the recognition of the correct initiation codon (6,7). Translational initiation in 
eukaryotes functions by a different mechanism. Eukaryotic mRNAs contain a co-
transcriptionally added 7-methylguanosine triphosphate cap at their 5′ ends and are post-
transcriptionally polyadenylated at their 3′ ends (8). Eukaryotic initiation factors bind the 5′ 
cap and 3′ poly(A) tail and provide a platform for binding by the small 40S ribosomal subunit 
(9). Once bound, the small subunit scans the mRNA in the 5′ to 3′ direction to locate the start 
codon.  
In contrast to these well developed models, the mechanism by which the translational 
start codon is recognized in mammalian mitochondria is unknown. Mammalian 
mitochondrial mRNAs do not have a SD sequence upstream of the start codon nor does the 
small subunit (28S) ribosomal RNA (12S rRNA) contain an anti-SD sequence (1). These 
mRNAs also lack a 5′ cap and thus resemble the rare leaderless mRNAs found in 
prokaryotes. Leaderless mRNAs in prokaryotes may actually be initiated on 70S ribosomes 
rather than on the 30S subunit (10,11).  
The fact that mitochondrial mRNAs are leaderless raises the question of whether 
information exists at or near the 5′ ends of these RNAs that enables them to be efficiently 
recognized by the mitochondrial translational machinery. No in vitro translational system that 
might allow a direct test of this question has been established for mammalian mitochondria, 
nor have any additional protein factors that function in start site selection been identified. It 
is, therefore, possible that the structure of the mRNA alone guides the ribosome to the proper 
start codon. This guiding or recognition function could be achieved by a conserved structural 
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element detected by the ribosome. Alternatively, it could be based on the unique accessibility 
of the start codon at the 5′ end of the mRNA. To begin to address these models, we have 
analyzed the secondary structure at the 5′ ends of all 13 protein coding regions in the bovine 
mitochondrial transcriptome at single nucleotide resolution using RNA SHAPE chemistry. 
Secondary structure predictions based on thermodynamic free energy minimization 
calculations indicate that the 5′ ends of many mitochondrial mRNAs can, in principle, form 
short stable secondary structures. In contrast to predictions based on free energy parameters 
alone, when experimental SHAPE information is used to constrain secondary structure 
predictions, we find that the 5′ ends of bovine mitochondrial mRNAs show a strong 
propensity to be highly unstructured. Our analysis indicates that the start codon tends to lie in 
a single-stranded region or in a very weak duplex stem. These data support a model in which 
translational initiation in mitochondria is not guided by a conserved secondary structural 
element but, instead, suggest that the mitochondrial ribosome recognizes structurally 
accessible and single stranded start codons. 
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FIGURE 2-1. The mitochondrial genome and strategy for analyzing the 5′ ends of 
mitochondrial mRNAs. (A) The mammalian mitochondrial genome encodes 13 proteins, 
each of which are subunits of the oxidative phosphorylation machinery. Protein coding genes 
and the 2 overlapping dicistronic mRNAs are shown explicitly. The protein encoding genes 
are generally separated by one or more tRNA genes (white); noncoding rRNA genes are 
green. (B) Messenger RNA fragments used for SHAPE analysis. The 5′ and 3′ extensions 
facilitate structural analysis of the 5′ end of the mRNA sequence and provide an efficient 
reverse transcriptase primer binding site, respectively.   
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MATERIALS AND METHODS 
 
 Plasmids: The plasmids p11-1 and p11-5 (12), containing the bovine mitochondrial 
genome, were kindly provided by Dr. Philip Laipis (University of Florida). The plasmid 
pTZ19R-CoII containing the bovine mitochondrial cytochrome oxidase subunit II gene was 
prepared as described (13).  
 
 RNA synthesis: DNA transcription templates containing the 5′ portion of each 
mRNA, flanked on either side by a stably folding structural cassette (14) were prepared by 
PCR. Reactions (100 µL) contained 10 mM KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl (pH 
8.8), 2 mM MgSO4, 0.1% Triton X-100, 250 µM each dNTP, 1 µM each forward and reverse 
primer, 15-30 ng linearized pTZ19R-CoII or 150-1,200 ng of linearized p11-1 or p11-5 
plasmid DNA and 0.02 units/µL of Vent DNA polymerase (NEB) and were subjected to 33 
cycles (denaturation at 95 ºC for 45 s; annealing 50-65 ºC for 30 s; elongation 72 ºC for 90 s). 
The specific primers (Table 2-1 and 2-2) and reaction conditions (Table 2-3) used to amplify 
each DNA are shown. The PCR product was recovered by ethanol precipitation and 
resuspended in 100 µL water. Transcription reactions (300 µL, 37 °C, 4-5 h) contained 40 
mM Tris-HCl, pH 7.6, 20 mM MgCl2, 2 mM spermidine, 10 mM dithiothreitol (DTT), 0.1 
mg/mL bovine serum albumin, 0.2 U/µL SUPERase•In RNase inhibitor, 4 mM each NTP, 
100 µL PCR-generated template, and a saturating amount of T7 RNA polymerase. The RNA 
product was precipitated with ethanol and resuspended in 100 µL water. The RNA was 
purified by denaturing (8%) polyacrylamide gel electrophoresis (29:1 
acrylamide:bisacrylamide prepared with 7 M urea, 90 mM Tris-borate, 2 mM EDTA), 
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visualized by UV shadowing, excised from the gel, recovered by passive elution in water and 
ethanol precipitation, and resuspended in 100 µL water.  
 
 SHAPE Analysis: RNA (4 pmol) in 24 µL water was heated at 95 °C for 2 min and 
then cooled on ice for 2 min. The RNA was treated with 12 µL folding buffer (333 mM 
HEPES-KOH, pH 8, 20 mM MgCl2, 333 mM NaCl) and incubated at 37 °C for 20 min. To 9 
µL (1 pmol) of the folded RNA, 1 µL of 130 mM N-methylisatoic anhydride (NMIA, 
Molecular Probes) in anhydrous dimethyl sulfoxide (DMSO) or 1 µL of anhydrous DMSO 
alone (control) was added and allowed to react at 37 °C for 45 min (15). The remaining 18 
µL of folded RNA was divided into 2 aliquots (1 pmol RNA/tube) and stored on ice for 
sequencing.  
 
 Primer Extension: To the NMIA treated, DMSO control, or untreated RNA (1 pmol), 
3 µL of a 0.3 µM 5′-[32P] radiolabelled oligonucleotide (5′-32P-GAACC GGACC GAAGC 
CCG or 5′-32P-GCGTG TGGTC ATGAA AGTG, obtained from the Nucleic Acids Core 
Facility at UNC) was added and the samples were incubated at 65 °C for 5 min and then at 
35 °C for 20 min for primer annealing. To each reaction, 6 µL of reverse transcription buffer 
(250 mM KCl, 167 mM Tris-HCl, pH 8.3, 17 mM DTT and 0.42 mM each dNTP) was 
added. For sequencing reactions using the untreated RNA, 2.5 µL of either 5 mM ddCTP or 
ddTTP were also added. After heating to 52 °C, 1 µL (200 Units) reverse transcriptase 
(Superscript III, InVitrogen) was added and the primer extension reaction was performed at 
52 °C for 3 min. Reactions were quenched with 1 µL of 4 M NaOH and heated at 95 °C for 5 
min. For gel analysis, 29 µL of a gel loading solution (40 mM Tris-borate, 5 mM EDTA, 276 
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mM unbuffered Tris-HCl, 0.01% (w/v) bromophenol blue and xylene cyanol and 73% (v/v) 
formamide) was added and the samples were heated at 95 °C for an additional 5 min (15).  
 
 Analysis: cDNA products from the (+) and (-) NMIA and sequencing reactions were 
separated by denaturing gel electrophoresis (10% polyacrylamide). Gels (21 cm x 40 cm x 
0.4 mm) were subjected to electrophoresis at 1400 V for 1.5 or 4 h. Bands were quantified by 
phosphorimaging (Molecular Dynamics). Band intensities in the (+) and (–) NMIA lanes 
were quantified using SAFA (16) and corrected for signal drop-off (17). Normalized SHAPE 
reactivities were calculated by subtracting intensities from the (-) NMIA control from the (+) 
NMIA reaction and divided by the average reactivity of the 8% most reactive positions. 
These reactivity values were then used as quasi-energetic constraints to constrain a 
thermodynamic folding algorithm, as implemented in RNAstructure (18); K.E. Deigan, T.W. 
Li, D.H. Mathews and K.M. Weeks, unpublished). Stabilities for individual helices, as 
reported in Figs. 2-2C through 2-14C, were calculated without adding SHAPE reactivities. 
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RESULTS 
 
 Strategy: To investigate the structure near the 5′ ends of mitochondrial mRNAs, RNA 
constructs containing approximately the first 70 nucleotides of each mRNA were prepared. 
The selected region of each mRNA was flanked on the 5′ end by an extension allowing 
structural analysis to include the entire 5′ end of the mRNA (Fig. 2-1B). On the 3′ end, the 
mRNA carried an extension that contained a strong primer binding site to ensure uniform 
reverse transcription (19). The structure formed by the first ~70 nucleotides of each of the 
mRNAs was then analyzed using RNA SHAPE chemistry (15).  
In a SHAPE experiment, local nucleotide flexibility is detected as the preferential 
ability of the 2′-hydroxyl group of nucleotides at conformationally dynamic sites to react 
with an electrophile to form a 2′-O-adduct.  The structure of each RNA was assessed by 
treating the RNA with N-methylisatoic anhydride (NMIA). Background was analyzed in a 
mock reaction omitting the reagent, performed in parallel. Sites of 2′-O-adduct formation 
were detected by primer extension. Two dideoxy sequencing reactions were performed in 
parallel to yield a sequencing ladder allowing identification of modified sites. The SHAPE 
extension reactions and sequencing ladders were resolved on a sequencing gel. The relative 
reactivities of each nucleotide were used as constraints in conjunction with structure 
prediction based on free energy minimization (18) to generate secondary structure models 
satisfying the imposed SHAPE constraints. We will focus on the analysis of three 
mitochondrial messages in detail (ND2, COIII and COII) and then briefly discuss the 
analysis and the experimentally supported structures for all 13 mRNAs (see Fig. 2-1A). 
56
 NADH Dehydrogenase Subunit 2 (ND2) mRNA: Of the 13 protein-coding 
sequences in the mitochondrial genome, seven open reading frames encode subunits of the 
NADH dehydrogenase complex (Complex I). Five of these are encoded as monocistronic 
mRNAs, while 2 are encoded in the form of the dicistronic ND4/4L transcript (20).  
In one representative example, we analyzed a 78 nucleotide fragment of the ND2 
mRNA using RNA SHAPE chemistry (Fig. 2-2). The RNA was folded in the presence of 
Mg
2+
 and subsequently treated with NMIA to assess local RNA structure or subjected to a 
mock reaction omitting the reagent to assess background. There were no significant stops in 
the control experiment omitting NMIA. In contrast, the RNA was highly modified upon 
treatment with the reagent [compare (+) and (-) NMIA lanes, Fig. 2-2A]. Reactivities were 
normalized to a scale spanning 0 to ~1.2 in which the average intensity of highly reactive 
positions was defined as having a reactivity of 1.0 (15). SHAPE reactivities can vary 
continuously from 0 to 1.2. To simplify visual analysis of this information, positions with 
high and medium reactivities will be colored red and yellow, respectively. Residues with 
little or no reactivity will be black. 
Most nucleotides between positions 1 and 45 in the ND2 mRNA are highly 
susceptible to modification, indicating that a considerable portion of this RNA is flexible and 
consequently, has little or no secondary or tertiary structure. While most nucleotides in this 
RNA are highly modified, nucleotides 46-56, 61-65 and 67-72 are unreactive toward NMIA 
(Fig. 2-2B). We used the experimental SHAPE reactivities to predict a secondary structure 
for this RNA (Fig. 2-2C). The predicted structure contains a single hairpin with a C bulge. 
The calculated free energy of this stem-loop is -6.3 kcal/mol (Fig. 2-2C). The SHAPE 
reactivities exactly match the predicted structure because unmodified nucleotides lie in the 
57
FIGURE 2-2. SHAPE analysis of the 5′ end of the ND2 mRNA. (A) Gel image showing the 
NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy sequencing 
ladders. (B) Histogram of normalized SHAPE reactivities after correcting for drop off. The 
histogram bar colors correspond to SHAPE reactivities. Nucleotides are defined as having a 
high reactivity (red), moderate reactivity (yellow) or low reactivity (black). (C) Predicted 
secondary structure for the 5′ end of the ND2 mRNA as constrained by SHAPE reactivities. 
Nucleotide colors correspond to those in panel (B). The reactivities for nucleotides 68-73 
were assigned by visual analysis of the gel. Although the first 10 nucleotides of this RNA 
have low (but still significant) reactivities, there are no obvious pairing partners for these 
positions in the RNA and flanking structure cassette. These nucleotides are thus predicted to 
be single stranded. 
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hairpin stem, while the single nucleotide bulge at position 66 is reactive. The remainder of 
this mRNA, including the AUA start codon, is predicted to be unstructured.  
These data emphasize the high degree of structural detail that can be obtained in a 
SHAPE analysis. Even though mitochondrial mRNAs contain a low fraction of guanine 
residues, it is still possible for these RNAs to form stable secondary structures as evidenced 
by the stem-loop at positions 46-72 in the ND2 message. This well defined stable structure 
stands in strong contrast to the first 45 nucleotides in the ND2 message, which are highly 
flexible and do not form a stable secondary structure (Fig. 2-2C).  
 
 Cytochrome Oxidase Subunit II and III mRNA:  Three subunits of cytochrome 
oxidase (Complex IV) in the oxidative phosphorylation pathway are encoded within the 
mitochondrial genome (COI, COII and COIII). The mRNA for the 30 kDa COIII subunit is 
781 nucleotides in length and begins with an AUG start codon. We used SHAPE chemistry 
to analyze a 5′ fragment of the COIII RNA in the context of the 5′ and 3′ extensions of the 
structure cassette. To address the general possibility that the 5′ extension might affect the 
structure of the internal mRNA, we analyzed the same COIII RNA fragment lacking the 5′ 
extension. Comparison of the reactivity profiles revealed that the 5′ extension had no 
significant effect on nucleotide reactivity [see (+) NMIA lanes in the extension and no 5′ 
extension lanes, Fig. 2-3A]. Comparison of the integrated SHAPE intensities shows that the 
reactivities for the two RNAs are essentially identical (blue and green bars, Fig. 2-3B) In 
both cases, the 5′ end of the RNA is predicted to form the same structure (Fig. 2-3C). This 
structure contains a set of two stem-loops, with the potential to stack coaxially. However, 
these structures are just barely stable and have a net free energy of formation of -0.7 and -0.3 
60
FIGURE 2-3. SHAPE analysis of the 5′ end of the COII mRNA. Panels A-C were generated 
as described for Fig. 2-2 with the following additions: (A) Gel image shows sites of 2′-O-
adduct formation for the 82 nucleotide long COII fragment and for the full length mRNA. 
(B) Histograms for the COII fragment and full length mRNA reactivities are in blue and 
green respectively. (C) Secondary structure model for the COII mRNA fragment. 
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kcal/mol. It is likely that there are multiple weak structures in equilibrium. The AUG start 
codon at the 5′ end is predicted to be fully unpaired. These experiments emphasize that the 
structure cassette does not affect the folding of the internal mRNA sequence and that the 5′ 
end of the COIII mRNA lacks significant structure. 
The mRNA for cytochrome oxidase subunit II (COII) is 684 nucleotides long and 
begins with an AUG start codon. For this RNA, we addressed the question of whether the 
structure of a 5′ fragment is a good model for the structure of the full mRNA. Hence, for this 
RNA, we analyzed both a 5′ fragment and an RNA spanning the full 684 nucleotides of the 
mRNA. This analysis allows us to assess whether long range pairings might be prevalent and 
affect the SHAPE profile at the 5′ ends of these RNAs. For both RNAs, SHAPE chemistry 
was performed under identical conditions and the sites of modification were analyzed using 
an internal DNA primer complementary to COII nucleotides 64-82 [compare ‘fragment’ and 
‘full length’ lanes, Fig. 2-4A]. The two RNAs have very similar SHAPE reactivity patterns 
[compare blue and green bars in the histogram, Fig. 2-4B]. Both reactivity patterns also 
support essentially the same structure for the 5′ end of this RNA with one minor difference. 
The full length data supports a slightly less stable structure in which the U-A pair at the base 
of the stem (shown in Fig. 2-3C) does not form. The overall secondary structure features a 
single stem-loop, interrupted by an internal loop that partially incorporates the AUG start 
codon (Fig. 2-4C). Although the stem-loop structure spans 28 nucleotides, its overall stability 
is still low and has a total free energy of only -3.2 kcal/mol. This analysis supports the 
conclusion that the ~70 nucleotides at the 5′ end of the mRNA yields a SHAPE profile and 
overall structure that is representative of the full length mRNA. 
63
FIGURE 2-4. SHAPE analysis of the 5′ end of the COIII mRNA. Panels A-C were 
generated as described for Fig. 2-2 with the following additions. (A) Gel image showing sites 
of 2′-O-adduct formation for the COIII mRNA fragment both with and without the 5′ 
extension from the structure cassette. G and A sequencing ladders correspond to the COIII 
RNA containing the 5′ extension. (B) Absolute SHAPE reactivities. Histograms for the COIII 
mRNA fragment without and with the 5′ extension are blue and green respectively. (C) 
Secondary structure model for the COIII mRNA fragment. Positions for which no data was 
obtained are gray. Identical structures are predicted for the RNAs without and with the 5′ 
extension.  
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 Other Monocistronic mRNAs: We analyzed 5′ RNA fragments for the other six 
monocistronic mRNAs in mammalian mitochondria. These included the remaining subunit of 
the cytochrome oxidase complex (COI, Fig. 2-5); the other four subunits of the NADH 
dehydrogenase complex (Figs. 2-6 – 2-9); and of cytochrome b (Cytb), which is the only 
subunit of complex III of the electron transfer chain encoded in the mitochondrial genome 
(Fig. 2-10). Strikingly, SHAPE analysis reveals that all of these RNAs are largely 
unstructured (note yellow and red nucleotides, Fig. 2-5 – 2-10). The most stable single 
secondary structural element is found in the COI RNA and consists of a reasonably stable 
stem-loop whose formation is 4.2 kcal/mol more stable than the corresponding single strand 
(Fig. 2-5C). Note that this stable stem lies 39 nucleotides from the 5′ end of this RNA such 
that the AUG start site is still in a conformationally flexible region (Fig. 2-5C). The 5′ 
regions of the remaining mRNAs are predicted to be essentially unstructured. For 
completeness, the most stable secondary structure for each RNA is shown as panel C in 
Figures 2-6 to 2-10 and none of these has a stability greater than 2.0 kcal/mol, a free energy 
increment equivalent to a single A-U base pair (21).  
 
 Dicistronic mRNAs: There are two dicistronic mRNAs in mammalian mitochondria. 
One of these encodes the ND4L and ND4 proteins, both subunits of Complex I. This mRNA 
initially codes for ND4L. The reading frames for the two proteins overlap such that the AUG 
start codon of ND4 is 1 nucleotide upstream of the stop codon for ND4L (Fig. 2-12).  The 
second dicistronic mRNA encodes ATPase subunit 8 (ATP8) as the first cistron and ATPase 
subunit 6 (ATP6) as the second cistron. Both of these subunits are components of 
66
FIGURE 2-5. SHAPE analysis of the 5′ end of the COI mRNA. (A) Gel image showing the 
NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy sequencing 
ladders. (B) Histogram of normalized SHAPE reactivities after correcting for drop off. The 
histogram bar colors correspond to SHAPE reactivities. Nucleotides are defined as having a 
high reactivity (red), moderate reactivity (yellow) or low reactivity (black). (C) Predicted 
secondary structure for the 5′ end of the COI mRNA as constrained by SHAPE reactivities 
with the start codon boxed. Nucleotide colors correspond to those in panel (B).  
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FIGURE 2-6. SHAPE analysis of the 5′ end of the ND1 mRNA. (A) Gel image showing the 
NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy sequencing 
ladders. (B) Histogram of normalized SHAPE reactivities after correcting for drop off. The 
histogram bar colors correspond to SHAPE reactivities. Nucleotides are defined as having a 
high reactivity (red), moderate reactivity (yellow) or low reactivity (black). (C) Predicted 
secondary structure for the 5′ end of the NDI mRNA as constrained by SHAPE reactivities 
with the start codon boxed. Nucleotide colors correspond to those in panel (B).  
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70
FIGURE 2-7. SHAPE analysis of the 5′ end of the ND3 mRNA. (A) Gel image showing the 
NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy sequencing 
ladders. (B) Histogram of normalized SHAPE reactivities after correcting for drop off. The 
histogram bar colors correspond to SHAPE reactivities. Nucleotides are defined as having a 
high reactivity (red), moderate reactivity (yellow) or low reactivity (black). (C) No secondary 
structure is predicted for the 5′ end of the ND3 mRNA when constrained by SHAPE 
reactivities. The start codon of the unstructured mRNA fragment is boxed. Nucleotide colors 
correspond to those in panel (B).  
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FIGURE 2-8. SHAPE analysis of the 5′ end of the ND5 mRNA. (A) Gel image showing the 
NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy sequencing 
ladders. (B) Histogram of normalized SHAPE reactivities after correcting for drop off. The 
histogram bar colors correspond to SHAPE reactivities. Nucleotides are defined as having a 
high reactivity (red), moderate reactivity (yellow) or low reactivity (black). (C) Predicted 
secondary structure for the 5′ end of the ND5 mRNA as constrained by SHAPE reactivities 
with the start codon boxed. Nucleotide colors correspond to those in panel (B).  
 
73
ACB
A
G
+N
M
IA
S
H
A
P
E
R
ea
ct
iv
ity
0.
7
0.
3
0
N
D
5
60
10
20
30
40 5
0
5'
  A
 U
 A
 A
 A
 C
 A
 U
 A
 U
 U
 C
 U
 C
 C
 U
 C
 A
 C
 U
 C
 U
 C
 A
 C
 U
   
 A
 C
 A
 C
 C
 C
 A
 U
 U
 A
 U
 A
 A
 U
 A
 A
 U
 A
 A
 
A 
   
U
G
   
 C
U
   
 A
U
   
 A
A 
   
U
CU
U
U
A
U U
C
A C
- 1
.0
1 9 18 31 42 51 58 63
N
uc
le
ot
id
e
10
20
30
40
50
60
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
1.
2
Reactivity
Fi
g.
 2
-8
74
FIGURE 2-9. SHAPE analysis of the 5′ end of the ND6 mRNA. (A) Gel image showing the 
NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy sequencing 
ladders. (B) Histogram of normalized SHAPE reactivities after correcting for drop off. The 
histogram bar colors correspond to SHAPE reactivities. Nucleotides are defined as having a 
high reactivity (red), moderate reactivity (yellow) or low reactivity (black). (C) Predicted 
secondary structure for the 5′ end of the ND6 mRNA as constrained by SHAPE reactivities 
with the start codon boxed. Nucleotide colors correspond to those in panel (B).  
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FIGURE 2-10. SHAPE analysis of the 5′ end of the CytB mRNA. (A) Gel image showing 
the NMIA modification reaction (+), the no reagent control (-), and G and A dideoxy 
sequencing ladders. (B) Histogram of normalized SHAPE reactivities after correcting for 
drop off. The histogram bar colors correspond to SHAPE reactivities. Nucleotides are 
defined as having a high reactivity (red), moderate reactivity (yellow) or low reactivity 
(black). (C) Predicted secondary structure for the 5′ end of the CytB mRNA as constrained 
by SHAPE reactivities with the start codon boxed. Nucleotide colors correspond to those in 
panel (B).  
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mitochondrial Complex V (the ATP synthase). The reading frames for these proteins overlap 
by 40 nucleotides (Fig. 2-14).  
The 5′ end fragments of both dicistronic mRNAs (corresponding to synthesis of 
ND4L and ATP8) were analyzed by SHAPE. Both RNAs have the ability to form single 
stem-loop structures (Figs. 6A and C); however, neither is more stable than a single G-C base 
pair (stabilities are -0.1 and -2.7 kcal/mol, respectively).  The start codon for both ND4L and 
ATP8 lie in very weakly or unstructured regions that would be readily accessible to the 
ribosome. Thus, the 5′ ends of the two dicistronic messages conform to the pattern identified 
for the monocistronic messages (Fig. 2-2C to 2-10C) and have no stable secondary structural 
elements near the 5′ start codons. 
We next analyzed fragments containing the overlapping coding regions for the 
ND4L/ND4 and ATP8/ATP6 messages, which spanned 88 and 92 nucleotides, respectively 
(Fig. 2-12 and 2-14). The start codon of ND4 and the stop codon of ND4L both lie in highly 
unstructured regions and both are predicted to be single-stranded. Moreover, these codons lie 
in a large unstructured domain. We speculate that the initiation of translation at the ND4 start 
site occurs by slippage of the ribosome or small subunit from the ND4L stop codon back to 
the ND4 start codon. However, if de novo initiation occurs, then the lack of structure may be 
important for facilitating the process. 
At the ATP8/ATP6 junction, there is also essentially no significant structure (Fig. 2-
14). Both the start codon of ATP6 and the stop codon of ATP8 lie in unstructured, and likely 
highly accessible, regions. There are 40 nucleotides between the beginning of the start codon 
of ATP8 and the end of the stop codon of ATP8. Initiation of translation of the ATP6 
message may require an independent initiation event, rather than ribosome slippage. An 
79
independent initiation event is likely to be strongly facilitated by the absence of structure in 
the region. One interesting observation in this case is the absence of AUG or AUA triplets in 
or around the overlapping reading frames, possibly facilitating correct translational initiation 
at the ATP6 start site. Interestingly, initiation of these internal messages occurs at the first 
codon located upstream of the stop codon for the initial message in RNA regions devoid of 
measurable secondary structure (Figs. 6B & D). 
80
FIGURE 2-11. SHAPE analysis of the 5′ translational start site for the ND4L dicistronic 
mRNA. (A) Gel image showing the NMIA modification reaction (+), the no reagent control 
(-), and G and A dideoxy sequencing ladders. (B) Histogram of normalized SHAPE 
reactivities after correcting for drop off. The histogram bar colors correspond to SHAPE 
reactivities. Nucleotides are defined as having a high reactivity (red), moderate reactivity 
(yellow) or low reactivity (black). (C) Predicted secondary structure for the 5′ end of the 
ND4L mRNA as constrained by SHAPE reactivities with the start codon boxed. Nucleotide 
colors correspond to those in panel (B).  
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82
FIGURE 2-12. SHAPE analysis at the junction between coding regions for the dicistronic 
ND4 mRNA. (A) Gel image showing the NMIA modification reaction (+), the no reagent 
control (-), and G and A dideoxy sequencing ladders. (B) Histogram of normalized SHAPE 
reactivities after correcting for drop off. The histogram bar colors correspond to SHAPE 
reactivities. Nucleotides are defined as having a high reactivity (red), moderate reactivity 
(yellow) or low reactivity (black). (C) Predicted secondary structure for the coding region 
junction of the dicistronic ND4 mRNA as constrained by SHAPE reactivities. The start 
codon for ND4 is boxed and the stop codon for the ND4L coding region is underlined. 
Nucleotide colors correspond to those in panel (B).  
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FIGURE 2-13. SHAPE analysis of the 5′ translational start site for the ATP8 dicistronic 
mRNA. (A) Gel image showing the NMIA modification reaction (+), the no reagent control 
(-), and G and A dideoxy sequencing ladders. (B) Histogram of normalized SHAPE 
reactivities after correcting for drop off. The histogram bar colors correspond to SHAPE 
reactivities. Nucleotides are defined as having a high reactivity (red), moderate reactivity 
(yellow) or low reactivity (black). (C) Predicted secondary structure for the 5′ end of the 
ATP8 mRNA as constrained by SHAPE reactivities with the start codon boxed. Nucleotide 
colors correspond to those in panel (B).  
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FIGURE 2-14. SHAPE analysis at the junction between coding regions for the dicistronic 
ATP6 mRNA. (A) Gel image showing the NMIA modification reaction (+), the no reagent 
control (-), and G and A dideoxy sequencing ladders. (B) Histogram of normalized SHAPE 
reactivities after correcting for drop off. The histogram bar colors correspond to SHAPE 
reactivities. Nucleotides are defined as having a high reactivity (red), moderate reactivity 
(yellow) or low reactivity (black). (C) Predicted secondary structure for the coding region 
junction of the dicistronic ATP6 mRNA as constrained by SHAPE reactivities. The start 
codon for ATP6 is boxed and the stop codon for the ATP8 coding region is underlined. 
Nucleotide colors correspond to those in panel (B).  
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DISCUSSION 
 
mRNA Structure in a Small Transcriptome 
  We have analyzed the 5′ ends of all translated RNAs in a single, small transcriptome. 
This analysis reveals that all 11 mRNAs in bovine mitochondria are highly unstructured. 
Specifically, as judged by SHAPE-constrained secondary structure prediction, there are no 
structures with a net stability greater than -3 kcal/mol in the first 35 nucleotides of any of 
these RNAs and, for most mRNAs, no structure forms that has a calculated stability of even -
1.0 kcal/mol (Figs. 2-2C to 2-11C, 2-13C).  
Mitochondrial genomes tend to be A/U rich and one explanation for the low extent of 
secondary structure might simply reflect the lower stability of A-U base pairs as compared 
with G-C base pairs. However, we find that some mRNA sequences do form stable 
secondary structures near their 5′ ends: the ND2 and COI messages contain stem-loops with 
calculated stabilities of -6.3 and -4.2 kcal/mol, respectively (Figs. 2-2C and 2-5C). These 
structures lie 45 and 39 nucleotides from the 5′ ends of their respective mRNAs. 
Furthermore, the structured mitochondrial tRNAs and rRNAs are also A/U rich indicating 
that the high A/U content by itself does not preclude the formation of significant structure. 
Thus, these data suggest mitochondrial mRNAs have the potential to form stable local 
structures but that such structures do not form near the 5′ ends of these mRNAs.  
 
Requirement for Experimental Information in Inferring Mitochondrial mRNA Structure 
We also assessed the extent to which the SHAPE reactivity information modulates the 
predicted secondary structure models for the mitochondrial mRNA leader sequences. In the 
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absence of experimental structural information, the most stable structure for an RNA can be 
estimated using thermodynamic parameters based on a dinucleotide sequence model, 
supplemented by other information for loops and multi-helix junctions (22-24). We 
calculated secondary structures for the 5′ ends of all 11 bovine mitochondrial mRNAs using a 
well-established thermodynamic model (18). In general, the 5′ ends of these leaderless 
mRNAs are predicted to contain significant structure with free energies ranging from -2.0 to 
-7.1 kcal/mol (Fig. 2-15).  
Comparison of the thermodynamic-only versus SHAPE-constrained predictions 
reveals that the differences fall into 3 classes. For three RNAs (ND2, ND5 and COI) the 
predicted models are identical. For the COIII RNA, there are minor differences between the 
structural models. In the third class, encompassing seven of the 11 leader sequences, there 
are large differences between the thermodynamic-only and SHAPE-constrained structures 
(compare structures in Fig. 2-15 with those in other figures). The differences between 
structures show a clear pattern. Structures predicted based on thermodynamic parameters 
alone contain many more base paired regions than do the SHAPE-constrained models. In 
general, the ‘extra’ helical regions tend to involve nucleotides that have high experimental 
SHAPE reactivities and, thus, are not consistent with direct experimental tests of these 
structures (see Fig. 2-15). These data are consistent with the general observation that 
thermodynamic models alone tend to over-predict secondary structures for RNAs of known 
structure (24). Importantly, the clear demonstration that the 5′ leaders of bovine 
mitochondrial mRNAs are characterized by a lack of stable secondary structure was 
dependent on having single nucleotide resolution SHAPE information. We hypothesize that 
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the conserved lack of structure at the 5′ ends of mitochondrial mRNAs plays a functional role 
in mitochondrial translational initiation.  
 
Structural Requirements for Translation Initiation in Mammalian Mitochondria 
Overall, the mechanism of translational initiation for the leaderless mitochondrial 
mRNAs remains poorly understood. This mechanism is likely to be distinct from initiation of 
leaderless mRNAs in prokaryotes. In prokaryotes, initiation of leaderless mRNAs is thought 
to occur on preformed 70S ribosomes rather than on the small subunit, as is the predominant 
mechanism in the cytoplasm of both prokaryotes and eukaryotes (5,9,11). In the model for 
leaderless prokaryotic translational initiation, IF2 promotes binding of fMet-tRNA to the 
intact 70S ribosome instead of to the small 30S ribosomal subunit (11). In contrast, the 
presence of an IF3 homolog in mitochondria (IF3mt) argues that initiation on mitochondrial 
mRNAs occurs on 28S subunits. IF3 functions to dissociate intact ribosomes into their 
constituent subunits, in both the prokaryotic and mitochondrial systems.  In prokaryotes, IF3 
antagonizes initiation of leaderless mRNAs, which require intact 70S ribosomes (11).  
Whereas, IF3mt stimulates initiation complex formation in the presence of mitochondrial 55S 
ribosomes (25). This stimulation is consistent with the ability of IF3mt to dissociate 55S 
ribosomes and, thereby, to increase the concentration of initiation-active 28S subunits (25). 
The small ribosomal subunit must then select the correct AUG or AUA start codon. 
The unifying characteristic among the mitochondrial mRNAs is that the start codon generally 
lies at the 5′ end of the message. SHAPE analysis indicates that all start codons in 
mammalian mitochondrial mRNAs lie in mRNA regions with little or no local structure. It is 
likely that this structural accessibility is important for providing a suitable platform for the 
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initiating ribosome, as has been suggested for the leaderless mRNAs found in the prokaryotic 
system (26).   
One of the most distinctive differences between mitochondrial and bacterial 
ribosomes is the presence of a triangular gate-like structure at the mRNA entrance site on the 
small subunit of the mitochondrial ribosome (27). The mRNA gate is formed almost 
completely by proteins that are specific to the mammalian mitochondrial ribosome. Thus, in 
the small 11 mRNA transcriptome of bovine mitochondria, both the mRNA start codon and 
also the mRNA entry site appear to have developed distinctive adaptations. The distinctive 
mitochondrial mRNA entry gate (27) may function to allow passage of only unstructured 
mRNA 5′ sequences into the small subunit for subsequent recognition of the start codon and 
translational initiation. 
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CHAPTER III 
 
A SINGLE POINT MUTATION IN HUMAN MITOCHONDRIAL tRNA
Met
 CAUSES 
DISEASE BY DISRUPTING Mg
2+
 BINDING LEADING TO tRNA MISFOLDING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JBC (in preparation) 
(This work in collaboration with Christopher Jones, William Graham and Paul Agris) 
 INTRODUCTION 
 
 Human mitochondria are subcellular organelles that produce more than 90% of the 
energy required by the cell. The mitochondrial genome encodes 13 proteins necessary for 
energy production, two rRNAs and all of the 22 tRNAs that are necessary for the synthesis of 
these proteins (1,2). Mammalian mitochondrial tRNAs have a number of unusual features 
that distinguish them from canonical tRNAs. In many cases, they lack a number of the 
conserved or semi-conserved nucleotides that play important roles in creating the L-shaped 
tertiary structure of prokaryotic and eukaryotic cytoplasmic tRNAs (3). There is little 
detailed structural information on these tRNAs. No data is currently available that examines 
the structure of mammalian mitochondrial tRNAs with single nucleotide resolution. 
However, chemical and enzymatic probing has lead to the idea that these tRNAs have 
retained the basic cloverleaf structure of canonical tRNAs but that they lack a number of 
conserved tertiary interactions leading to a weaker tertiary structure (4-8). In particular, a 
number of the long-range interactions between the D-and T-arms of the tRNAs appear to be 
missing. 
All 22 tRNAs that function in mammalian mitochondria are encoded in the 
mitochondrial DNA. Considerable interest in mitochondrial tRNAs centers on the occurrence 
of diseases arising from mutations in their genes that lead to a number of maternally inherited 
genetic disorders (9-12). The diseases associated with mitochondrial tRNA mutations may 
arise from failure in the processing of the tRNA (13), from reduced stability of the tRNA 
(14,15), from a reduction in aminoacylation (12,16,17), from a reduced ability of the mutated 
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 aminoacyl-tRNA to interact with mitochondrial elongation factor Tu (EF-Tumt) (16) and from 
the failure of the tRNA to be correctly modified leading to translational defects (18).  
Normally, protein biosynthetic systems have two tRNA
Met
 species. One is used solely 
for initiation while the other functions in polypeptide chain elongation. Animal mitochondria 
are quite unusual in that they contain a single gene for tRNA
Met
, which functions in both 
polypeptide chain initiation and chain elongation. As a result of this dual role, mitochondrial 
Met-tRNA
Met
 must be recognized by the mitochondrial Met-tRNA transformylase (MTFmt) 
and be brought as fMet-tRNA
Met
 to the ribosome for translational initiation. In addition Met-
tRNA
Met
 must interact with elongation factor EF-Tumt and bind to the A-site of the ribosome 
during translational elongation. Thus, this tRNA
Met
 is of central importance in mitochondrial 
translation. 
Human tRNA
Met
 has a number of interesting features (Fig. 3-1A). The D-loop is 
somewhat small and lacks the classical GG sequence found in most tRNAs. It has no 
dihydrouridine modification. The D-loop lacks the G at 19 that facilitates interactions with 
the T-loop through the tertiary interaction G19 with C56. The first position of the anticodon 
contains the unusual modified base 5-formylcytidine. This modification may play a role in 
the unusual codon recognition requirements of this tRNA which must recognize both AUG 
and AUA codons. The minor loop is short lacking the usual G47 and the T-stem has two 
adjacent pyrimidine:pyrimidine pairs (U-U and U-Ψ). Further, the T-loop contains only 6 
nucleotides instead of the normal 7. These unusual structural features suggest that human 
mitochondrial tRNA
Met
 may have an intrinsically weak tertiary structure.  
Three interesting point mutations (T4409C, A4435G and G4450A) occur in the gene 
for human tRNA
Met
 (hmtRNA
Met
). The T4409C mutation (Fig. 3-1A) results in a U8 to C 
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 change at the corner of the acceptor stem and D-stem of hmtRNA
Met
. This mutation leads to 
mitochondrial myopathy resulting in dystrophic muscles and exercise intolerance (19). The 
A4435G mutation leads to the change of A37 to G37 in the anticodon loop of the tRNA (20). 
This mutation acts as a modulator of Leber’s hereditary optic neuropathy increasing the 
severity of this condition when it arises due to other mutations in the mitochondrial DNA. 
The G4450A mutation leads to loss of the final base pair in the T-stem (Fig. 3-1A). This 
mutation presents as splenic lymphoma, is largely confined to lymphocyte cells, and results 
in severely abnormal mitochondria leading to serious defects in energy production (21). A 
systematic examination of the structural and biochemical consequences of these mutations is 
lacking. Here we examine the structure of human mitochondrial tRNA
Met
 and probe the 
effects of the U8C mutation on the structure and function of this tRNA.  
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FIGURE 3-1: The sequence of the normal and U8C hmtRNA
Met
 and the effect of the 
mutation on the aminoacylation of the tRNA. (A) Primary sequence of hmtRNA
Met
 indicating 
the position of the U8C mutation. The Sprinzl numbering system is used throughout (40). (B) 
Aminoacylation of the normal (circles) and U8C transcripts (squares) of hmtRNA
Met
 by 
hmMetRS. (C) Aminoacylation of the normal (circles) and U8C transcripts (squares) of 
hmtRNA
Met
 by E. coli MetRS.  
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 MATERIALS AND METHODS 
 
 RNA synthesis: Human mitochondrial tRNA
Met
 transcripts for aminoacylation 
experiments were prepared by in vitro transcription (22), purified by denaturing (10%) 
polyacrylamide gel electrophoresis (29:1 acrylamide:bisacrylamide prepared with 7M urea, 
90 mM Tris-borate, 2 mM EDTA), visualized by UV shadowing, excised from the gel and 
recovered by passive elution in water followed by ethanol precipitation. HmtRNA
Met
 
transcripts for selective 2′-hydroxyl acylation and primer extension (SHAPE) experiments 
were prepared in the context of the structure cassette as described (23). D- and T-half 
molecules were chemically synthesized (Dharmacon), purified and analyzed as previously 
described (24). 
 
Purification of E. coli MetRS: A saturated overnight culture of JM109 cells carrying 
the pQE60-E. coli MetRS plasmid construct (kindly provided by Uttam RajBhandary, MIT) 
was grown at 37 °C in 2xYT media (20 mL) supplemented with 50 µg/mL Ampicillin and 
used to inoculate 2 L of 2xYT media (50 µg/mL ampicillin). The cells were grown at 37 °C 
for 4 hours (A600= 0.6), induced with 50 µM isopropyl-β-D-thiogalactopyranoside (IPTG) 
and then grown at 37 °C for 4 h post-induction. The cells were harvested by centrifugation at 
4000 rpm for 30 min. The cell pellet was resuspended in 500 mL of 10 mM Tris-HCl (pH 
7.6) and then re-collected by low speed centrifugation. The cell pellet was fast frozen and 
stored at -80 °C until used for purification of MetRS as described below. 
The cell pellet (7 g) was resuspended in 100 mL of lysis buffer (50 mM Tris-HCl pH 
7.6, 50 mM KCl, 10 mM MgCl2, 200 µM phenylmethylsulphonyl fluoride (PMSF), 0.1% 
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 Triton X-100 and 7 mM β-mercaptoethanol (βME)) and sonicated on ice for 7 min with 10 s 
bursts followed by a 50 s cooling periods. The cell lysate was separated by centrifugation at 
15k rpm for 30 min at 4 °C. E. coli MetRS was purified from the supernatant using 400 µL of 
a 50% Ni-NTA slurry in wash buffer (100 mM Tris-HCl, pH 7.6, 1 M KCl, 10 mM MgCl2, 
10 mM imidazole, 200 µM PMSF and 7 mM βME). The resin was washed with 200 mL of 
wash buffer. The protein was eluted with 4 mL of elution buffer (100 mM Tris-HCl, pH 7.6, 
50 mM KCl, 10 mM MgCl2, 150 mM imidazole, 200 µM PMSF and 7 mM βME). The 
protein sample was dialyzed against 2 volumes of 500 mL of dialysis buffer (50 mM Tris-
HCl pH, 7.6, 50 mM KCl, 2.5 mM MgCl2, 0.1 mM EDTA, 10% glycerol and 7 mM βME) 
for 1 h. 
 
Purification of bovine MTFmt: A saturated culture of E. coli BL21 cells carrying the 
pET15-bovine MTFmt plasmid construct (kindly provided by Nono Takeuchi, Univ. of 
Tokyo) was grown at 37 °C in LB media (20 mL, with 50 µg/mL ampicillin) and used to 
inoculate 2 L of LB media (50 µg/mL ampicillin). The cells were grown at 37 °C until an 
A600 of 0.6 was reached, induced with 140 µM IPTG and then grown at 18 °C overnight (~16 
h). The cells were harvested by low speed centrifugation. The cell pellet was washed with 
500 mL of 50 mM Tris-HCl, pH 7.6 and then re-collected by low speed centrifugation. The 
cell pellet was fast frozen and stored at -80 °C until used for purification of MTFmt as 
described below. 
The cell pellet (9 g) was resuspended in 100 mL of MTF lysis buffer (50 mM Tris-
HCl, pH 7.6, 40 mM KCl, 7 mM MgCl2, 10% glycerol, 100 µM PMSF, 0.1% Triton X-100 
and 7 mM βME) and sonicated on ice for 7 min with 10 s bursts followed by a 50 s cooling 
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 periods. The cell lysate was separated by centrifugation at 15k rpm for 30 min at 4 °C. 
MTFmt was purified from the supernatant using 600 µL of a 50% Ni-NTA slurry in MTF 
wash buffer (50 mM Tris-HCl, pH 7.6, 1 M KCl, 7 mM MgCl2, 10 mM imidazole, 10% 
glycerol and 7 mM βME). The resin was washed with 100 mL of MTF wash buffer. The 
protein was eluted with 6 mL of MTF elution buffer (50 mM Tris-HCl, pH 7.6, 40 mM KCl, 
7 mM MgCl2, 150 mM imidazole, 10% glycerol and 7 mM βME). The protein sample was 
dialyzed against 2 volumes of 500 mL of MTF dialysis buffer (20 mM Tris-HCl, pH 7.6, 100 
mM KCl, 10% glycerol and 3 mM βME) for 1 h. 
  
 Aminoacylation of human mitochondrial tRNA
Met
: The aminoacylation reactions for 
both the wild-type and U8C mutant tRNA
Met
 transcripts were performed essentially as 
described (22). Reaction mixtures (100 µL) containing 50 mM Tris-HCl, pH 7.6, 2.5 mM 
MgCl2, 2.5 mM ATP, 200 nM spermine, 200 µg/mL BSA, 0.2 U/µL SUPERase•In RNase 
Inhibitor, 40 µM [
35
S] methionine (4000 cpm/pmol), 50 nM human mitochondrial MetRS 
(hmMetRS, prepared as described (22)) or 8 nM E. coli MetRS and 1 µM U8 or U8C 
hmtRNA
Met
 were used.  
 
SHAPE analysis of wild-type and U8C mutated hmtRNA
Met
 transcripts: Wild-type 
or U8C mutated tRNA (14 pmol, 0.33 µM) in 42 µL of nuclease free water (Ambion) was 
incubated at 50 °C for 2 min and then cooled on ice for 2 min. The RNA was divided into 
two aliquots of 12 µL (4 pmol) and 24 µL (8 pmol). The 4 pmol of RNA was treated with 6 
µL of no Mg
2+
 folding buffer (333 mM Hepes-KOH, pH 8, 333 mM NaCl) and the 8 pmol of 
RNA was treated with 12 µL of with Mg
2+
 folding buffer (333 mM Hepes-KOH, pH 8, 20 
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 mM MgCl2, 333 mM NaCl) and incubated at 37 °C for 20 min. To 1 µL of 100 mM 1-
methyl-7-nitro-isotoic anhydride (1M7) in anhydrous DMSO or 1 µL of anhydrous DMSO 
(control), 9 µL (2 pmol) of folded RNA was added and allowed to react at 37 °C for 70 s (5 
half lives). The remaining 18 µL of folded RNA was divided into 2 aliquots of 9 µL (2 pmol) 
each and stored at 37 °C for sequencing. To the RNA treated with the no Mg
2+
 folding buffer 
1 µL of 64 mM MgCl2 was added. To the 1M7 treated, DMSO treated or untreated RNA (2 
pmol), 3 µL of a 0.3 µM 5′-[32P] radiolabelled oligonucleotide (5′-32P-
GAACCGGACCGAAGCCCG, obtained from the Nucleic Acids Core Facility at UNC) was 
added and the samples were incubated at 65 °C for 5 min and then at 35 °C for 20 min for 
primer annealing. To each reaction, 6 µL of reverse transcription buffer (250 mM KCl, 167 
mM Tris-HCl, pH 8.3, 17 mM DTT and 0.42 mM each dNTP) was added. To the untreated 
RNA 1 µL of 5 mM ddCTP or ddTTP (Amersham) was added. After heating to 52 °C, 1 µL 
(200 Units) reverse transcriptase (Superscript III, InVitrogen) was added and the primer 
extension reaction was performed at 52 °C for 5 min. Reactions were quenched with 1 µL of 
4 M NaOH and heated at 95 °C for 5 min. For gel analysis, 29 µL of a gel loading solution 
(138 mM unbuffered Tris HCl, 73% (v/v) formamide, 2 mM Tris-borate, 86 mM EDTA pH 
8, with xylene cyanol and bromophenol blue) was added and the samples were heated at 95 
°C for an additional 5 min. The cDNA products from the (+) and (-) 1M7 and sequencing 
reactions were separated by denaturing gel electrophoresis (10% polyacrylamide). Gels (21 
cm x 40 cm x 0.4 mm) were electrophoresed at 1400 V for ~2.5 h. Gels were visualized by 
phosphorimaging (Molecular Dynamics). The (+) and (-) 1M7 band intensities were 
quantified using SAFA (25) and corrected for signal drop-off (26). SHAPE reactivities were 
normalized by subtracting intensities from the (-) 1M7 control from the (+) 1M7 reaction and 
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 divided by the average reactivity of the most reactive 7%. The reactivity of each nucleotide 
was assigned a value between 0 and 1. Nucleotides fall into 1 of 4 categories; unreactive (0-
0.055), low reactivity (0.055-0.11), moderately reactive (0.11-0.22) or highly reactive (0.22-
1). 
 
Structural Studies of hmtRNA
Met
 half molecules: Reconstitution of hmtRNA
Met
 
from U8 and U8C D-half molecules with T-half molecules required Mg
2+
 and was assessed 
by gel mobility shift assays using native, 15% polyacrylamide gel electrophoresis in Tris-
borate buffer (89 mM Tris base, 89 mM boric acid, pH 8.3) with and without 3 mM Mg
2+
 at 
4 °C (24). The concentration of the D-half molecule was held constant at 31.2 µM while the 
concentration of the T-half molecule was varied from 4.2 to 112 µM.  
 
UV monitored thermodynamic experiments: The half-molecule RNA samples were 
dissolved in the above Tris-borate buffer used for the PAGE experiments to obtain a 
concentration of 1.2 µM. MgCl2 was added to a concentration of 3 mM. UV-monitored, 
thermal denaturations and re-naturations were replicated 10 times and monitored by 
measuring UV absorbance (260 nm) using a Cary 3 spectrophotometer as published (27,28). 
The data points were averaged over 20 s and recorded with a temperature change of 1 °C per 
min from 4 to 90 °C. The least inconsistent of the ten melting transitions (either a 
denaturation or renaturation) was discarded from each set and the resulting data averaged on 
a point-by-point basis. The data was analysed as described by Serra and Turner (29) and the 
thermodynamic parameters were determined using Meltwin (30).  
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 For UV melts, the normal U8 tRNA and the U8C hmtRNA
Met
 was dialyzed against 
water using 10 kDa cutoff dialysis cups (Stratagene). The U8 and U8C hmtRNA
Met
 
transcripts were diluted to 0.5 M in a buffer containing 10 mM NaCl and 10 mM HEPES-
KOH, pH 8.0. The thermal denaturation of the tRNAs was monitored by UV absorbance at 
260 nm using a Cary 3 spectrophotometer. Data points were recorded once per min from 4-
95 °C with a temperature change of 1 °C per min. Following thermal renaturation, 6 mM 
Mg
2+
 was added to the U8 and U8C transcripts and the UV-monitored thermal denaturation 
experiments were repeated.  
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 RESULTS 
 
Aminoacylation of the normal and U8C mutated tRNA
Met
: Previous studies (22) 
have shown that the transcript of mitochondrial tRNA
Met
 has aminoacylation properties 
similar to those observed with the native tRNA. The U8C mutation leads to a myopathy 
presumably arising from a reduction in translational activity in mitochondria. To determine 
the biochemical consequence of the U8C mutation, the ability of the U8 and U8C 
hmtRNA
Met
 transcripts to be aminoacylated by the human mitochondrial methionyl-tRNA 
synthetase (hmMetRS) was tested. Aminoacylation is an early step required for the tRNA to 
be used in either the elongation or initiation phase of protein synthesis, and is, thus, of central 
importance for protein synthesis in mitochondria. The normal U8 transcript aminoacylates as 
expected (22); however the U8C mutation causes a drastic reduction in the rate of 
aminoacylation of the tRNA (Fig. 3-1B).  
Interestingly, though U8C hmtRNA
Met
 is anemically aminoacylated by hmMetRS, it 
is not aminoacylated at all by E. coli MetRS (Fig. 3-1C). The hmMetRS is believed to be 
both structurally and functionally homologous to its prokaryotic counterpart (22). However, 
this work demonstrates that the hmMetRS is less discriminatory than E. coli MetRS for the 
structure of the tRNA. Since a major determinant in the recognition of tRNA
Met
 by the 
MetRS is thought to lie in the anticodon sequence which is unchanged (31), this observation 
then leads to the question of why the mutated tRNA is less active in aminoacylation. 
 
 Chemical probing of the structure of the normal U8 tRNA
Met
 in the presence and 
absence of Mg
2+
: The structures of the hmtRNA
Met
 transcript containing the normal U8 and 
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 the transcript containing the disease causing U8C mutation were probed using SHAPE 
chemistry (23,32). SHAPE chemistry relies on the differential reactivity of the 2′ OH of 
nucleotides in different conformational states within the RNA (single stranded versus base 
paired) to the small molecule 1-methyl-7-nitroisatoic anhydride (1M7) (23,32). Residues in 
flexible regions of the RNA are preferentially modified by this reagent. The tRNA was 
reverse transcribed using a radio-labeled primer and sites of modification were identified 
based on their ability to obstruct reverse transcription. The cDNA products were analyzed on 
a denaturing polyacrylamide gel. When residues in unstructured or flexible regions of the 
tRNA are modified, the reverse transcriptase stops, leading to a labeled band observed on the 
gel one residue shorter than the position of the modification. Comparison of the position of 
these bands to a sequencing ladder allows the identification of residues susceptible to 
modification (33). The reactivity of each nucleotide toward 1M7 is quantified and the relative 
reactivity of each nucleotide is assigned a value between 0 and 1. The higher the value, the 
more propensity the nucleotide has to be unstructured. This information allows us to evaluate 
the legitimacy of the modeled tRNA structure (34).  
SHAPE chemistry was performed on the normal U8 hmtRNA
Met
 transcript in the 
presence of Mg
2+
 (Fig. 3-2A). A number of distinct structural features can be observed (Fig. 
3-2B). No modification is observed for residues predicted to form the acceptor stem and the 
D-stem indicating that they are largely paired as expected. A single residue in the D-loop is 
highly reactive suggesting that most of the residues in this region of the tRNA are involved in 
tertiary interactions that reduce their reactivity. The anticodon stem is clearly protected, but, 
as expected, residues in the anticodon loop are available for modification. The variable loop 
again shows limited modification indicating tertiary interactions. These interactions are 
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FIGURE 3-2: Structural consequence of the U8C mutation in hmtRNA
Met
 and the effect of 
Mg
2+
. (A) Gel image showing the reactivity to 1M7 of the U8 hmtRNA
Met
 transcript. 
Reactions were performed in the presence (lane 3) and absence (lane 1) of Mg
2+
 and control 
reactions were performed lacking 1M7. Dideoxy NTP sequencing reactions were also 
performed and those gel bands are 1 nucleotide longer than the corresponding bands in the 
reaction lanes. The reactivities of the various tRNA loops are highlighted. A line on the gel 
indicates the acceptor stem. Bands above the 5′ end of the acceptor stem correspond to the 
structure cassette. (B) The structure of the hmtRNA
Met
 transcript indicating structural regions 
of interest. The U8 which is changed in the U8C tRNA is red. (C) Gel image showing the 
1M7 reactivity of the U8C hmtRNA
Met
 in the presence (lane 3) and absence (lane 1) of Mg
2+
. 
The gel is annotated as in A. (D) The structure formed by the U8C hmtRNA
Met
 transcript in 
the presence of Mg
2+
 with the mutated nucleotide, C8, shown in red. 
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FIGURE 3-3: Tertiary interactions in the hmtRNA
Met
 and the effect of mutating U8 to C on 
these interactions. (A) Histogram showing the reactivity of nucleotides in the U8 hmtRNA
Met
 
transcript. Nucleotides with high, medium, low and no reactivity are shown in red, orange, 
green and black respectively. Structural regions in the tRNA are shown above the histogram. 
(B) The L-shaped structure of hmtRNA
Met
. Possible tertiary interactions occurring in the 
tRNA are shown and are based on conserved interactions in canonical tRNAs. The 
nucleotides are colored based on reactivity as in A. (C) The histogram showing the reactivity 
of nucleotides in the U8C hmtRNA
Met
. The histogram is labeled and colored as in A. (D) A 
possible unfolded structure of the mutated U8C hmtRNA
Met
 is shown with the nucleotides 
colored based on the nucleotide reactivity shown in the histogram in C. The Sprinzyl 
numbering system is used. 
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 expected to take place primarily with residues in the D-loop as would be expected from 
tertiary contacts observed in canonical tRNAs. The T-stem apparently forms despite the 
presence of the U-U pairs. However, in contrast to other tRNAs (35), residues in the T-loop 
are quite reactive indicating that they are accessible in the tertiary structure of this tRNA.  
A more thorough analysis of the SHAPE data through quantitation of the individual 
nucleotide reactivities provides additional insight into the 3-dimensional structure formed by 
the unusual hmtRNA
Met
. The SHAPE reactivity pattern is suggestive of a fully folded L-
shaped tRNA and is similar to the reaction pattern observed with other tRNAs (35) (Fig. 3-
3A). Superimposition of the nucleotide reactivities on the L-shaped tRNA structure (34) (Fig. 
3-3B) provides additional information about possible tertiary interactions within the tRNA. 
For clarity, we have colored nucleotides according to their level of reactivity. As expected, 
the most reactive portion of the tRNA is the anticodon loop. The reactivity data support a 
structure in which many of the conserved canonical tertiary interactions are preserved. For 
example, nucleotides U8, A14, and A21 which in canonical tRNAs, form a triple base pair 
are all modestly reactive or non-reactive in hmtRNA
Met
. Other possible preserved tertiary 
interactions are shown in Fig. 3-3B and include the expected interaction between nucleotides 
in the D-loop and the variable loop such as between A15 and U48.  
Despite the likely presence of many conserved tertiary interactions in hmtRNA
Met
, 
other interactions are probably not occurring due to the shortened sequence of this tRNA. For 
example, interactions between the D- and T-loops may be different than in canonical tRNAs 
since the D-loop is short and lacks the common GG sequence while the T-loop is only 6-
nucleotides instead of the universal 7-nucleotides found in classical tRNAs. Also, A58 in the 
T-loop is not reactive while its expected partner U54 shows significant reactivity, suggesting 
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 that this expected canonical tertiary interaction may not occur. This may be indicative of 
significant differences in the tertiary interactions occurring in the T-loop of this tRNA when 
compared to a canonical tRNA. 
The reactivity of 1M7 is not Mg
2+
-sensitive, hence, SHAPE chemistry was used to 
examine the influence of Mg
2+ 
on the structure formed by the hmtRNA
Met
. As indicated in 
Fig. 3-2A (compare lanes 1 and 3) the structure of this tRNA is sensitive to the presence of 
Mg
2+
 as would be expected for stabilization of the negatively charged backbone. In the 
absence of Mg
2+
, the tRNA structure is opened and highly reactive with 1M7 indicating that 
both secondary and tertiary interactions have been lost (Fig. 3-2A lane 1).  
 
Chemical probing of the structure of the U8C mutated tRNA in the presence and 
absence of Mg
2+
: The structure of the U8C mutated hmtRNA was probed in the presence of 
Mg
2+
 (Fig. 3-2C, lane 3). The single nucleotide mutation (U8C) at the corner of the acceptor 
stem and D-stem of the hmtRNA
Met
 results in a drastic loss of structure that is seen even in 
the presence of Mg
2+ 
(Fig. 3-2C, lane 3). An increase in reactivity is seen in the region of the 
D-loop, the variable loop, acceptor stem and T-stem. For example, all of the residues in the 
D-loop and most of the residues in the variable loop are now reactive. Further, the residues in 
the acceptor stem, which are base paired in the wild-type tRNA, are now reactive. Only the 
G•C pairs of the anticodon stem appear to be forming stably in the mutated tRNA (Fig. 3-
2D). These changes indicate that the tertiary structure and a large portion of the secondary 
structure have been lost due to the mutation.  
As expected, this tRNA, like the wild-type hmtRNA has essentially no structure in 
the absence of Mg
2+
 (Fig. 3-2C lane 1). Even the anticodon stem has now melted. Clearly, 
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 the mutated tRNA has lost most of its Mg
2+
 sensitivity so that even the presence of Mg
2+
 is 
not sufficient to correctly fold the tRNA. It is likely that the loss in structure observed upon 
mutation of U8C results from a loss of stabilizing tertiary interactions that are present in the 
wild-type tRNA and that are dependent on the presence of Mg
2+
.  
Analysis of the U8C mutated tRNA clearly shows a global increase in reactivity (Fig. 
3-3C and D). This increase is seen in all of the stems accept the anticodon stem suggesting a 
loss of these secondary structural elements. Both the D- and T-loops also significantly 
increase in reactivity, suggesting a loss in stabilizing tertiary interactions. The variable loop, 
which makes extensive tertiary interactions in the U8 hmtRNA
Met
, becomes highly reactive 
in the U8C tRNA. While the mutated U8C residue itself shows only a slight increase in 
reactivity, its tertiary interaction partners, A14 and A21, become highly reactive suggesting 
that they are unable to form the necessary stabilizing tertiary interactions in this region of the 
tRNA. When these reactivities are superimposed on the L-shaped hmtRNA
Met
 structure it is 
clear that changing the single U8 nucleotide to a C results in loss of both secondary and 
tertiary interactions resulting in a tRNA that is largely unstructured (Fig. 3-3D).  
 
Association of T-half molecules with U8 and U8C D-half molecules: The secondary 
structure probing was performed on an in vitro transcript of the tRNA, which replaces two 
pseudouridines (Ψ27 and Ψ50) with uridines and a single 5-formylcytosine (C34) with cytosine 
(36). To further probe the effect of the U8C mutation on the structure of the tRNA, D- and T-
domain tRNA half molecules were prepared containing the two pseudouridines and either U8 
or U8C in the D-half molecule (Fig. 3-4A). Previously, we demonstrated that incubation of 
the wild type D- and T-half molecules of bovine mtRNA
Met
 in the presence of Mg
2+
 resulted 
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 in reconstitution of the mtRNA
Met
 (24). The reconstituted tRNA could be observed as a slow 
moving band under native conditions in polyacrylamide gel electrophoresis (PAGE). The 
effect of the U8C mutation on the reconstitution of the human mtRNA
Met
 was assessed using 
PAGE migration in the presence and absence of Mg
2+
. The thermal stabilities of the U8 and 
U8C D-half molecules and the wild type T-half molecule were also determined in the 
presence and absence of Mg
2+
. 
In PAGE, when the slower migrating mtRNA
Met
 D-half molecule containing the 
normal U8 is titrated with the faster migrating T-half molecule at 3 mM Mg
2+
, a gel shift is 
observed which corresponds to the formation of a complex between the two half molecules 
(Fig. 3-4C) (24). In fact, two new bands attributed to the reconstituted tRNA appear to 
increase with increasing amounts of the T-half molecule. This increase is accompanied by the 
expected decrease in the D-half molecule (Fig. 3-4C). The two gel bands attributed to the 
reconstituted mtRNA
Met
 contained both half molecules, as determined by denaturing PAGE 
(data not shown). The slower moving mtRNA
Met
 approximated 70% of the reconstituted 
tRNA and migrated in a fashion similar to that of E. coli cytoplasmic tRNA (Fig. 3-4C), and 
to the migration found for the complex of bovine mtRNA
Met
 half molecules (24). The faster 
moving band representing some 30% of the reconstituted human mtRNA
Met
 migrated faster 
than the D-half and slower than the T-half. It is believed to be folded into a second, but non-
native, conformation. In the absence of Mg
2+
 the migration of the D-half molecule is more 
rapid than in the presence of Mg
2+
 suggesting a Mg
2+
-dependent conformational change in 
the half molecule. In the absence of Mg
2+
, the two half molecules could not form a complex 
(Fig. 3-4C and D). 
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FIGURE 3-4: Effect of Mg
2+
 and the U8C mutation on complex formation between the 
tRNA D-half and T-half molecules. (A) The D-half molecule (A1- C32, pink) and the T-half 
molecule (A33-A76, blue) were chemically synthesized to include Ψ27 and Ψ50. (B) Summary 
of the efficiency of complex formation between the normal (purple) and mutated (green) D-
half and T-half molecules in the presence of Mg
2+
. (C) Titration of the U8 D-half molecule 
(D) with increasing concentrations of the T-half molecule (T) at 3 mM Mg
2+
 showing the 
formation of two complexes (C1 and C2). (D) Titration of the U8 D-half molecule with 
increasing concentrations of the T-half molecule in the absence of Mg
2+
 showing that no 
complex is formed. (E) Titration of the U8C D-half molecule with increasing concentrations 
of the T-half molecule at 3 mM Mg
2+
 showing that little complex is formed. (F) Titration of 
the U8C D-half molecule with increasing concentration of the T-half molecule in the absence 
of Mg
2+
 showing that no complex is formed. The first lane labeled wt D/T is a positive 
control showing the formation of the complex between the wild-type D-half molecule (37.6 
µM) and the wild-type T-half molecule (37.1 µM). The lane labeled Dm indicates the 
migration of the mutated D-half molecule alone, while the T lane indicates the migration of 
the wild-type T-half molecule. Done in collaboration with C. Jones, W. Graham and P. Agris 
(NCSU).  
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 The mutated U8C D-half and wild-type T-half molecules are incapable of forming a 
complex either in the presence or absence of Mg
2+
 (Fig. 3-4E, F and B). The migration of the 
mutant U8C D-half molecule is much faster than the wild-type D-half in the presence of 
Mg
2+
, suggesting a conformational difference in the half molecule resulting from the U8C 
change. In addition, the rapid migration of the U8C D-half molecule was not affected by 
Mg
2+
. These results suggest that the U8C D-half molecule has lost the ability to bind one or 
more structurally important Mg
2+ 
ions.  
Native gel electrophoresis was also carried out on the hmtRNA
Met
 transcripts in the 
presence and absence of Mg
2+
 (data not shown). There was a noticeable shift to a slower 
migration of the U8C transcript in the presence of Mg
2+
 compared to the wild-type. In the 
absence of Mg
2+
 only a slight difference in migration was observed. This data again indicates 
that the U8C and wild-type transcripts respond differently to Mg
2+
.  
 
Thermal denaturation of the mutated tRNA: The addition of counterions, 
particularly Mg
2+
, to RNA stabilizes its structure. Apparently, the U8C D-half molecule has 
lost the ability to bind one or more critical Mg
2+
. We are able to observe this difference 
between the U8 and U8C D-half molecule by UV-monitored denaturation and renaturation. 
In the absence of Mg
2+
, the U8 D-half molecule began to denature at low temperatures, but 
did exhibit a major transition (Fig. 3-5A). However, in the presence of Mg
2+
, the RNA 
melted earlier and with a lower hyperchromicity. This response to Mg
2+
 is similar to that of 
the bovine mtRNA
Met
 D-half molecule (24).  
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 In contrast, the thermal denaturation of the human mtRNA
Met
 U8C D-half molecule 
lacked a major thermal transition, and was little effected by the presence of Mg
2+
 (Fig. 3-5B). 
This observation again argues that the mutation has led to the loss of a Mg
2+
 binding site.  
The wild type T-half molecule exhibited a major thermal transition that was stabilized 
by the presence of Mg
2+
 (Fig. 3-5C). This is surprising considering that the T-stem contains 
two adjacent U-U mismatches (Fig. 3-1A). However, tandem U-U mismatches form one of 
the most stable internal loops in RNA and, despite the stem distortion that results, their 
presence actually stabilizes duplex RNA (37,38).  
Thermal denaturation of the intact U8 hmtRNA
Met
 transcript similarly demonstrates 
the importance of Mg
2+
 for correctly folding of hmtRNA
Met
. In the absence of Mg
2+
 the U8 
tRNA began melting at low temperatures, but demonstrated a major transition at around 30 
°C (Fig. 3-6A, blue). In the presence of Mg
2+
 the U8 tRNA was stably folded until about 
50°C were a major transition occurred (Fig. 3-6A, pink). The shift in melting temperature in 
the presence of Mg
2+
 demonstrates the increased structure resulting from the presence of 
Mg
2+
. Conversely, melting the U8C hmtRNA
Met
 transcript did not show a strong dependence 
on Mg
2+
. In both the presence and absence of Mg
2+
 the U8C transcript failed to show a major 
thermal transition, although significant hyperchromicity was observed (Fig. 3-6B). Clearly 
the U8C tRNA does not show the same structural response to Mg
2+
 as the U8 tRNA. 
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FIGURE 3-5: Effect of Mg
2+ 
on the thermal stabilities of the hmtRNA
Met
 wild type and 
mutant D-half molecules and the wild type T-half molecule. The wild type (A) and mutant 
(B) D-half molecules and the wild type T-half molecule (C) were subjected repeatedly to 
thermal denaturation and renaturation monitored at 260 nm. The average of nine melt profiles 
conducted on different days are plotted for each RNA in the absence (blue) and presence 
(pink) of 3 mM Mg
2+
. Done in collaboration with C. Jones, W. Graham and P. Agris 
(NCSU).  
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FIGURE 3-6: Thermal denaturation of the U8 and U8C transcripts in the presence and 
absence of Mg
2+
. (A) The thermal denaturation of the U8 transcript was monitored at 260 nm 
in the absence (blue) and presence (pink) of 6 mM Mg
2+
. (B) The U8C transcript in the 
absence (blue) and presence (pink) of 6 mM Mg
2+
 was subjected to thermal denaturation 
monitored at 260 nm. 
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 DISCUSSION 
 
 The data presented here represent the first analysis of the structure of a human 
mitochondrial tRNA at single nucleotide resolution. Our data indicate that, despite an overall 
weaker structure, hmtRNA
Met
 displays an overall secondary and tertiary structure that is 
compatible with the L-shaped structure of canonical tRNAs. The drastic effect of the U8C 
mutation on the ability of this tRNA to fold even in the presence of Mg
2+
 suggests that the 
nucleotide at position 8 is critical for the structure of this tRNA and for the ability of the 
tRNA to take advantage of the stabilization from a site-specifically bound Mg
2+
.  
 The crystal structure of
 
yeast tRNA
Phe
 clearly shows that Mg
2+
 binds tightly and site 
specifically to binding pockets formed by tertiary interactions in the tRNA (39). It is believed 
that formation of these binding pockets precedes Mg
2+
 binding, and that the subsequent 
binding of Mg
2+
 then stabilizes the 3-dimensional architecture of the tRNA (39). A single 
tightly coordinated Mg
2+
 is bound at the elbow of tRNA
Phe
. The binding site for this ion is 
formed by nucleotides in the D-arm and at the corner of the D-stem and acceptor stem (Fig. 
3-7A). The phosphate of U8 contacts this Mg
2+
 through a bridging water molecule. U8 is also 
involved in a triple non-Watson-Crick pairing interaction with nucleotides A14 and A21 
forming the binding pocket (Fig. 3-7B). Our work suggests that mutation of this single 
nucleotide to cytosine (U8C) in hmtRNA
Met 
prevents formation of this Mg
2+
 binding pocket, 
resulting in a tRNA that fails to fold in the presence of Mg
2+
. The loss of the structure of the 
tRNA could occur because of a disruption in the base pairing between nucleotides U8 and 
either A14 or A21, that in turn would destabilize the sharp turn and the Mg
2+ 
binding pocket. 
Alternatively, loss of structure could result from an inability to properly coordinate the Mg
2+
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 ion via a water molecule in the pocket. Without the stabilizing effect of Mg
2+
 bound at this 
site, a drastic loss of structure results leading to a tRNA that is not readily aminoacylated. 
 Interestingly, in canonical tRNAs U8 is highly conserved and is considered a 
universal nucleotide (Fig. 3-7C) underlying the critical role of this nucleotide in forming the 
site-specific Mg
2+
 binding pocket that leads to a correctly folded, functional L-shaped tRNA. 
Of the 22 tRNAs present in human mitochondria, 16 of them have a U at position 8 and 14 of 
them have the U8--A14--A21 combination seen in hmtRNA
Met
. It is of interest to note that 
the most common mutation in human mitochondrial tRNAs (the A3243G mutation in the 
tRNA
Leu
 gene associated with MELAS) is the mutation of A14 to G. The extremely 
deleterious effect of this mutation is also likely to arise from an inability to form the tertiary 
interaction involving the U8--A14--A21 triple base triple.   
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FIGURE 3-7: The location of the Mg
2+
 binding pocket in yeast tRNA
Phe
 involving the 
highly conserved U8. (A) Tertiary structure of yeast tRNA
Phe
 showing the Mg
2+
 (green) 
bound near U8. The tRNA is colored by secondary structure domain. The acceptor arm is 
light pink, the T-arm is light blue, the D-arm is sky blue, the anticodon arm is pink, the 
variable loop is yellow, the corner of the D-stem and acceptor stem is orange, the ACCA end 
is grey, and the Mg
2+
 is green. (B) Close-up view of the Mg
2+
 binding pocket colored as in A. 
(C) Table showing conservation of U8 among various organisms and organelles. The 
conservation of U8 in mammalian mitochondrial is shown in pink. 
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